{"gene":"NR2C2","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":1994,"finding":"TR4 (NR2C2) was identified as a member of the steroid receptor superfamily, cloned from human and rat hypothalamus/prostate/testis, encoding a 615 (human) or 596 (rat) amino acid protein with high homology to TR2, establishing TR2 and TR4 as a unique subfamily within the nuclear receptor superfamily.","method":"cDNA cloning, sequence analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — original cloning paper with sequence determination and structural characterization, independently replicated across species","pmids":["8016112"],"is_preprint":false},{"year":1997,"finding":"TR4 binds with high affinity (Kd = 0.066 nM) to a conserved DR1 hormone response element (CNTFR-DR1) in the 5th intron of the CNTFRα gene and induces its enhancer activity in a dose-dependent manner, identifying CNTFRα as the first neural-specific gene transactivated by TR4.","method":"EMSA, reporter gene (CAT) assay, in situ hybridization","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA plus reporter assay in single lab, two orthogonal methods","pmids":["9006963"],"is_preprint":false},{"year":1997,"finding":"TR4 binds DR4-HRE with strong affinity (Kd = 2 nM) and induces transcription from DR4-containing promoters (including rat α-myosin heavy chain and S14), in contrast to its repressive activity on DR1-HRE targets, demonstrating element-dependent bidirectional transcriptional regulation.","method":"EMSA, Scatchard analysis, CAT reporter assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA with quantitative binding plus functional reporter assay, single lab","pmids":["9115296"],"is_preprint":false},{"year":1998,"finding":"TR4 represses RA-induced transactivation via a negative feedback mechanism by binding DR1 and DR5 elements (RAR and RXR response elements) with higher affinity than RAR/RXR, and RA treatment increases TR4 mRNA and protein levels in F9 cells, establishing a negative feedback loop.","method":"EMSA, CAT reporter assay, Western blot, Northern blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (EMSA, reporter, protein/mRNA), single lab","pmids":["9593676"],"is_preprint":false},{"year":1998,"finding":"TAK1/TR4 binds DR1 response elements as a homodimer with greatest affinity for AGGTCAAAGGTCA, represses PPARα-mediated transactivation by competing with PPARα/RXR for PPRE binding, and also competes with PPARα for the co-activator RIP-140 (shown by two-hybrid analysis); TR4 does not heterodimerize with PPARα or RXRα.","method":"Site selection analysis, gel shift assay, cell transfection/reporter assay, two-hybrid analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (binding, reporter, protein interaction), single lab","pmids":["9556573"],"is_preprint":false},{"year":1998,"finding":"TR2 and TR4 preferentially form heterodimers in solution and on DR5-containing DNA elements; the dimerization is mediated by the ligand-binding domains with three leucine residues on helix 10 of TR2 being critical; coexpression of TR2 and TR4 exerts stronger repressive activity on DR5-reporter than either receptor alone.","method":"Yeast two-hybrid, mammalian two-hybrid, pull-down assay, EMSA, GFP intracellular localization tracking, reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods including in vitro pulldown, two-hybrid systems, EMSA, and live-cell imaging with mutagenesis of critical residues","pmids":["9737983"],"is_preprint":false},{"year":1998,"finding":"TR4 crosstalks with COUP-TF1 and thyroid hormone receptor (TRα1) to potentiate HIV-LTR transcriptional activity, while TR4 alone has no effect on HIV-LTR; TR2 does not show this crosstalk activity, demonstrating TR4-specific functional interaction with other nuclear receptors.","method":"Gel retardation assay (EMSA), CAT reporter assay, transient transfection","journal":"Endocrine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, reporter assay only, no direct protein interaction demonstrated","pmids":["9704574"],"is_preprint":false},{"year":1998,"finding":"TR4 suppresses estrogen receptor-mediated transactivation in bone cells (osteosarcoma cell lines) but not in kidney or breast cancer cells, establishing a bone cell-specific repressor activity of TR4 on ER signaling.","method":"Transient transfection assay, Northern blot","journal":"Endocrinology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, functional reporter in cell lines only, no direct protein interaction assay","pmids":["9421416"],"is_preprint":false},{"year":1998,"finding":"CNTF increases TR4 expression and enhances TR4 DNA-binding capacity; TR2 expression is also induced by CNTF and TR2 induces CNTFRα transcriptional activity via CNTFR-I5 DR element, establishing bidirectional regulation between TR2/TR4 and the CNTF signaling pathway.","method":"EMSA, reporter assay, in situ hybridization, Western blot","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA plus reporter plus in vivo expression, single lab","pmids":["9694834"],"is_preprint":false},{"year":1999,"finding":"TR4 binds DR3VDRE with high affinity (Kd = 1.32 nM) and represses vitamin D3 target gene (25-hydroxyvitamin D3 24-hydroxylase) expression, in contrast to its induction of DR4T3RE target genes; distinct TR4 conformations when bound to DR3VDRE vs. DR4T3RE (shown by antibody supershift and proteolytic analysis) allow recruitment of different coregulators.","method":"EMSA, cell transfection/reporter assay, antibody supershift, proteolytic analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative binding, functional assay, conformational analysis using multiple techniques, single lab","pmids":["10347174"],"is_preprint":false},{"year":2002,"finding":"TR4 directly interacts with estrogen receptor (ER) via protein-protein interaction, inhibits ER homodimerization, and prevents ER binding to estrogen response elements, resulting in suppression of ER target genes (cyclin D1, pS2) and inhibition of ER-mediated cell proliferation in MCF-7 cells.","method":"EMSA, GST pull-down assay, reporter assay, stable transfection, cell proliferation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — GST pulldown demonstrating direct interaction plus EMSA for functional consequence, single lab, two orthogonal methods","pmids":["11844790"],"is_preprint":false},{"year":2002,"finding":"The DRED (direct repeat erythroid-definitive) repressor complex contains TR2 and TR4 as a heterodimer that binds DR1 sites in human embryonic ε-globin and fetal γ-globin gene promoters; DRED is a ~540 kDa complex; TR2/TR4 binding is reduced by an HPFH mutation in the DR1 site; forced transgenic TR2/TR4 expression reduces embryonic εy-globin transcription.","method":"Biochemical purification, mass spectrometry/sequence determination, EMSA, transgenic mouse model","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — purification and sequencing of endogenous complex, EMSA, and in vivo transgenic validation, multiple orthogonal methods","pmids":["12093744"],"is_preprint":false},{"year":2002,"finding":"A novel TR4-associated protein TRA16 (16 kDa, 139 amino acids, nuclear localization) selectively represses TR4-mediated transactivation by interacting with TR4 DNA-binding and ligand-binding domains; TRA16 reduces TR4 binding to TR4RE without inhibiting TR4 homodimerization; TRA16 blocks TR4-LBD interaction; the repression is TR4-selective (minimal effect on AR, GR, PR).","method":"Mammalian two-hybrid, Co-IP, EMSA, reporter assay, confocal microscopy","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus two-hybrid plus EMSA plus functional reporter, single lab with multiple orthogonal methods","pmids":["12486131"],"is_preprint":false},{"year":2003,"finding":"TR4 binds to a DR1 element (TR4RE-HBV) in the HBV core promoter and suppresses pre-core and core mRNA transcription; TR4 suppresses HBV core promoter by repressing HNF4α-mediated transactivation through protein-protein interaction (TR4 N- and C-terminal regions required), without inhibiting HNF4α DNA binding.","method":"EMSA, luciferase reporter assay, primer extension, co-immunoprecipitation, deletion/domain analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple complementary methods including EMSA, reporter, and protein interaction, single lab","pmids":["12522137"],"is_preprint":false},{"year":2003,"finding":"TR4 induces apoE gene expression via a TR4 response element in the hepatic control region 15 kb downstream of the apoE gene, and also regulates apoC-I and apoC-II expression via the same hepatic control region TR4RE; TR4 forms a complex with Sp1 for synergistic apoE induction via a proximal promoter DR0 element; TR4 knockout mice show significantly reduced serum apoE protein and liver apoE mRNA.","method":"Gel shift assay, luciferase reporter, TR4 knockout mice, quantitative analysis of serum/mRNA levels","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vitro binding/reporter complemented by in vivo knockout mouse validation, single lab but multiple orthogonal methods","pmids":["12954636"],"is_preprint":false},{"year":2004,"finding":"TIP27, a novel 27 kDa zinc finger protein, interacts specifically with the TR4 ligand-binding domain (helix 3 to C-terminus) via its TAK1-interaction domain (residues Asp39–Lys79) and functions as a selective repressor of TR4/DR1-dependent transactivation without inhibiting TR4 homodimerization or DNA binding, suggesting repression via interference with co-activator recruitment.","method":"Yeast two-hybrid, mammalian two-hybrid, pull-down assay, confocal microscopy, reporter assay","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast and mammalian two-hybrid plus pull-down plus localization, single lab","pmids":["15302918"],"is_preprint":false},{"year":2005,"finding":"TR4 induces apoE expression in multiple cell lines via binding to a DR0 element (TR4RE-DR0-apoE at -303 to -292 bp) in the apoE 5' proximal promoter, and forms a complex with Sp1 to synergistically induce apoE expression.","method":"Gel shift assay, luciferase reporter assay, RT-PCR, Western blot","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, overlapping with prior study (PMID 12954636), no in vivo validation","pmids":["15670754"],"is_preprint":false},{"year":2007,"finding":"TR2 and TR4 are stage-selective repressors of embryonic β-type globin genes in vivo: Tr2 and Tr4 null mutant mice show delayed silencing of εy and βh1 globins in definitive erythroid cells; dominant-negative TR4 activates human ε-globin in both primitive and definitive erythroid cells but activates γ-globin only in definitive cells; forced TR2/TR4 expression causes precocious ε-globin repression but paradoxically induces γ-globin in definitive erythroid cells.","method":"Knockout and transgenic mouse models, gene expression analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic in vivo mouse models (null mutants, dominant-negative, transgenic overexpression) with defined gene-specific phenotypes","pmids":["17431400"],"is_preprint":false},{"year":2007,"finding":"TR2 and TR4 directly repress Gata1/GATA1 transcription in murine and human erythroid progenitor cells through an evolutionarily conserved DR element in the GATA1 hematopoietic enhancer; TR2/TR4 binds this site in vitro and in vivo; mutation of the DR element elevates Gata1 promoter activity and reduces responsiveness to cotransfected TR2/TR4.","method":"Knockout and transgenic mouse models, ChIP, EMSA, reporter assay, shRNA knockdown in human CD34+ cells","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP in vivo, EMSA in vitro, mutagenesis of binding site, multiple genetic models","pmids":["17974920"],"is_preprint":false},{"year":2007,"finding":"TR4 knockout mice show significantly reduced PEPCK expression and impaired gluconeogenesis; TR4 transactivates the PEPCK promoter by direct binding to a TR4RE at -451 to -439 bp; TR4 knockdown in hepatocytes reduces glucose production; ectopic TR4 expression increases PEPCK expression and hepatic glucose production.","method":"Knockout mice, EMSA, ChIP, luciferase reporter assay, siRNA/RNAi in hepatocytes, glucose production assay","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro binding/reporter validated by in vivo knockout mouse plus siRNA, multiple orthogonal methods","pmids":["17827404"],"is_preprint":false},{"year":2009,"finding":"TR4 induces CD36 expression transcriptionally by binding to a TR4 response element in the CD36 5' promoter; this transactivation is enhanced by polyunsaturated fatty acids (omega-3/-6) and their metabolites (15-HETE, 13-HODE) and by rosiglitazone (TZD); TR4 knockout mice show reduced CD36 expression and foam cell formation; TR4 acts as a fatty acid sensor.","method":"TR4 knockout mice, EMSA, ChIP, siRNA knockdown, cDNA rescue, foam cell formation assay, reporter assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro binding (EMSA, ChIP) plus in vivo knockout plus siRNA/rescue experiments, multiple orthogonal methods","pmids":["19666541"],"is_preprint":false},{"year":2010,"finding":"Crystal structure of the TR4 ligand-binding domain reveals an autorepressed conformation: the LBP is filled by the C-terminal half of helix 10 and the AF-2 helix occupies the cofactor binding site; retinol and retinoic acid promote TR4 to recruit coactivators and activate TR4-regulated reporters; mutations disrupting cofactor binding, dimerization, or ligand binding substantially reduce TR4 transcriptional activity.","method":"X-ray crystallography, coactivator recruitment assay, reporter assay, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional mutagenesis and ligand binding assays, multiple orthogonal methods","pmids":["21068381"],"is_preprint":false},{"year":2010,"finding":"TAK1/TR4 knockout mice are resistant to age- and high-fat-diet-induced metabolic syndrome; TR4 deficiency reduces hepatic triglyceride levels, lipid accumulation in adipose tissue, adipose inflammation, and insulin resistance; TR4 regulates lipogenic genes (Cidea, Cidec, Mogat1, CD36) in liver; TR4 knockout mice show increased energy expenditure.","method":"TR4 knockout mice, gene expression profiling, histochemical/biochemical analysis, metabolic studies, primary hepatocyte rescue experiments","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — comprehensive knockout mouse study with multiple metabolic phenotypic readouts and gene expression profiling, single lab but extensive characterization","pmids":["20864514"],"is_preprint":false},{"year":2010,"finding":"Genome-wide ChIP-seq of TR4 in 4 human cell types shows that less than 30% of TR4 binding sites contain a DR1 motif (derived from in vitro studies), and ~30% of TR4 sites are co-occupied by the ETS factor ELK4 at sites lacking DR1, suggesting TR4 can be recruited to chromatin via protein-protein interaction with ETS factors.","method":"ChIP-seq, bioinformatics/motif analysis, ELK4 ChIP-seq","journal":"BMC genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide ChIP-seq with co-occupancy analysis, single lab, correlation-based finding for ELK4 interaction","pmids":["21126370"],"is_preprint":false},{"year":2011,"finding":"TR2 and TR4 recruit multiple epigenetic corepressor complexes (DNMT1, NuRD, LSD1/CoREST, HDAC3, TIF1β) specifically to embryonic β-globin promoters but not the adult β-globin promoter in adult erythroid cells; at least four distinct TR2/TR4 molecular complexes exist; upon terminal erythroid differentiation, corepressors dissociate from adult but not embryonic globin promoters.","method":"ChIP, biotin-tag purification of TR2/TR4 complexes, mass spectrometry, co-immunoprecipitation, erythroid differentiation assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — endogenous complex purification with MS identification plus reciprocal Co-IP plus ChIP, multiple orthogonal methods, single lab","pmids":["21670149"],"is_preprint":false},{"year":2011,"finding":"TR4 knockout mice develop mitochondrial myopathy with reduced complex I activity, decreased mitochondrial ATP production, and increased serum lactate; TR4 transcriptionally regulates the complex I assembly factor NDUFAF1; restoration of TR4 or NDUFAF1 in TR4-/- myoblasts rescues mitochondrial ATP generation and complex I activity.","method":"TR4 knockout mice, histology, ATP production assay, complex I activity assay, qPCR, promoter study, rescue experiments","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knockout plus in vitro biochemical assays plus promoter studies plus rescue experiments, multiple orthogonal methods","pmids":["21622535"],"is_preprint":false},{"year":2011,"finding":"TR4 knockout mice show premature aging with increased genome instability and defective oxidative stress defense; TR4-/- MEFs show rapid growth arrest and reduced resistance to oxidative stress and DNA damage; restoring TR4 or adding antioxidant NAC reduces DNA damage in TR4-/- MEFs; TR4 loss alters genes in DNA damage response and anti-ROS pathways.","method":"TR4 knockout mice, MEF culture, DNA damage assays, qPCR array, NAC rescue, oxidative stress assays","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo knockout plus in vitro rescue, multiple phenotypic readouts, single lab","pmids":["21521714"],"is_preprint":false},{"year":2011,"finding":"ARA55 functions as a corepressor of TR4 by enhancing acetylation of TR4 at conserved lysine residues K175 and K176 in the DNA-binding domain via recruiting histone acetyltransferase activity, thereby significantly reducing TR4 DNA-binding activity and suppressing TR4 transactivation.","method":"Mutation analysis, co-IP, reporter assay, DNA binding assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis of specific acetylation sites combined with functional reporter and DNA binding assays, single lab","pmids":["21515881"],"is_preprint":false},{"year":2011,"finding":"Forced TR2/TR4 expression in sickle cell disease model mice increases fetal hemoglobin (HbF) from 7.6% to 18.6% of total hemoglobin, increases hematocrit, reduces reticulocytes, and reduces hepatosplenomegaly, demonstrating that TR2/TR4 can paradoxically induce γ-globin in adult definitive erythroid cells.","method":"Transgenic mouse model (humanized sickle cell model), hemoglobin analysis, hematological measurements, histology","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo transgenic mouse model with multiple hematological readouts validating mechanism","pmids":["22042865"],"is_preprint":false},{"year":2011,"finding":"TR4 transcriptionally regulates GADD45A through TR4 response elements located in intron 3 of the GADD45A gene; TR4 deficiency abrogates Gadd45a expression and increases IR-induced cell death; IR increases TR4 expression in normal but not TR4 knockdown cells.","method":"ChIP, luciferase reporter assay, qPCR, shRNA knockdown, TR4 knockout MEFs, irradiation assay","journal":"Cellular & molecular biology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter with mutagenesis plus functional cell-death assay, single lab","pmids":["22396141"],"is_preprint":false},{"year":2012,"finding":"TR4 knockout mice develop osteoporosis with reduced osteoblast activity; TR4 directly binds the promoter region of osteocalcin and induces its transcription; osteoblast progenitor cells from TR4 knockout mice show reduced differentiation and calcification with decreased expression of ALP, type I collagen α1, osteocalcin, PTH, and PTHR.","method":"TR4 knockout mice, bone analysis, primary osteoblast culture, alkaline phosphatase/alizarin red staining, luciferase reporter, ChIP, EMSA","journal":"Reproductive biology and endocrinology : RB&E","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knockout mouse plus in vitro direct binding (ChIP, EMSA) plus reporter assays, multiple orthogonal methods","pmids":["22676849"],"is_preprint":false},{"year":2013,"finding":"TR4 is overexpressed in human corticotroph tumors and transcriptionally activates proopiomelanocortin (POMC) via binding a DR1 response element in the POMC promoter; this activation is enhanced by MAPK-mediated TR4 phosphorylation; forced TR4 overexpression increases ACTH secretion, cellular proliferation, and tumor invasion in vitro and promotes corticotroph tumor growth in vivo.","method":"Overexpression/knockdown in cell lines, reporter assay, luciferase assay with MAPK inhibitors, xenograft mouse model, ACTH/corticosterone measurement","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic dissection in vitro with DR1 binding plus MAPK modification plus in vivo tumor model validation, multiple methods","pmids":["23653479"],"is_preprint":false},{"year":2013,"finding":"TR4 promotes prostate cancer CD133+ stem/progenitor cell chemoresistance via a TR4→Oct4→IL1Ra axis; TR4 knockdown reduces Oct4 expression which reduces IL1Ra expression; restoring Oct4 or IL1Ra in TR4-knockdown cells reverses chemosensitivity.","method":"siRNA/lentiviral knockdown, drug sensitivity (IC50) assay, apoptosis assay, neutralization experiments","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis-style rescue experiments establishing pathway order, single lab","pmids":["23609451"],"is_preprint":false},{"year":2014,"finding":"Mycobacterium tuberculosis keto-mycolic acid acts as a heterologous ligand for TR4, binding with energetically favorable thermodynamics (isothermal titration calorimetry); this keto-MA–TR4 interaction induces foamy macrophage formation and granuloma development in vitro and in vivo.","method":"Transactivation assay, promoter reporter assay, TLC, NMR, isothermal titration calorimetry, in vitro and in vivo granuloma models","journal":"Journal of immunology (Baltimore, Md. : 1950)","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — direct ligand-binding assay (ITC) plus functional transactivation plus structural identification (NMR/TLC), single lab","pmids":["24907344"],"is_preprint":false},{"year":2014,"finding":"TR4 promotes prostate cancer metastasis by transcriptionally upregulating CCL2; ChIP and luciferase assays confirmed TR4 binding to the CCL2 promoter; CCR2 antagonist reverses TR4-enhanced PCa cell migration/invasion in vitro and PCa metastasis in orthotopic mouse model.","method":"siRNA/cDNA overexpression, migration/invasion assay, ChIP, luciferase assay, orthotopic xenograft mouse model","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter plus in vivo mouse model, single lab","pmids":["24975468"],"is_preprint":false},{"year":2014,"finding":"TR4 functions as a tumor suppressor during PCa initiation by transcriptionally regulating ATM expression; TR4 knockdown increases DNA damage and reduces ATM levels; ATM restoration partially reverses TR4-siRNA-induced tumorigenesis; three mouse models support TR4's suppressor role.","method":"TR4 knockout mouse models, siRNA knockdown, cell transformation assay, ATM rescue experiment, IHC, qPCR","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple mouse models plus rescue experiment, single lab","pmids":["24583925"],"is_preprint":false},{"year":2014,"finding":"TR4 directly binds the pyruvate carboxylase (PC) promoter via a TR4 responsive element and increases PC gene expression and activity in 3T3-L1 adipocytes; TR4-mediated fatty acid synthesis requires PC activity, as siRNA knockdown of PC or PC inhibition abolishes TR4-enhanced fatty acid synthesis.","method":"Luciferase reporter assay, ChIP (implied by direct binding), siRNA, PC activity assay, radiolabeled carbon incorporation assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — binding/reporter plus biochemical activity assay plus siRNA epistasis, single lab","pmids":["25240193"],"is_preprint":false},{"year":2015,"finding":"Compound conditional knockout of Tr2 and Tr4 in adult bone marrow cells leads to induced expression of embryonic εy and βh1 globins, confirms loss of TR2/TR4 occupancy at embryonic globin promoters and impairs co-occupancy by interacting corepressors; TR2/TR4 function is also required for terminal erythroid cell maturation.","method":"Conditional knockout mouse model, in vitro bone marrow differentiation, globin expression analysis, ChIP","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout (avoiding embryonic lethality) with ChIP demonstrating direct occupancy loss, extends prior genetic evidence","pmids":["25561507"],"is_preprint":false},{"year":2015,"finding":"TR4 increases prostate cancer invasion by decreasing miR-373-3p expression, which activates TGFβR2/p-Smad3 signaling; in vivo orthotopic mouse model confirmed TR4-increased PCa metastasis is mediated through decreased miR-373-3p.","method":"Overexpression/knockdown, invasion assay, miRNA expression analysis, orthotopic xenograft mouse model","journal":"Oncotarget","confidence":"Low","confidence_rationale":"Tier 3 / Weak — correlative pathway dissection without direct binding evidence for TR4 on miR-373-3p promoter, single lab","pmids":["25980442"],"is_preprint":false},{"year":2015,"finding":"TR4 transcriptionally regulates TIMP-1 and MMP2; knockdown of TR4 in PCa cells suppresses macrophage infiltration via increasing TIMP-1 with decreased MMP2; TIMP-1 neutralizing antibody reverses the effect, establishing TR4→MMP2/TIMP-1 axis in macrophage-mediated PCa invasion.","method":"siRNA knockdown, macrophage migration assay, invasion assay, TIMP-1 neutralization, IHC of patient samples","journal":"Molecular cancer","confidence":"Low","confidence_rationale":"Tier 3 / Weak — indirect mechanistic evidence without direct TR4 binding to target gene promoters, single lab","pmids":["25623427"],"is_preprint":false},{"year":2017,"finding":"SIRT7 deacetylates DDB1 at Lys1121, reducing its binding to DCAF1, thereby attenuating CUL4B/DDB1/DCAF1 E3 ubiquitin ligase activity and increasing TR4 protein levels; K1121R-DDB1 (deacetylation mimic) shows reduced DCAF1 binding and elevated TR4 and TR4 target gene expression (Cd36, Cidea, Cidec, Pparg1).","method":"Co-IP (SIRT7-DDB1 interaction), site-directed mutagenesis (K1121R), overexpression, Western blot, qPCR","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct interaction demonstrated, mutagenesis validates mechanism, functional target gene readout, single lab","pmids":["28623141"],"is_preprint":false},{"year":2017,"finding":"TR4 plays a distinct individual role in erythroid development beyond TR2/TR4 redundancy: Tr4 null mutation in congenic C57BL/6 background causes early embryonic lethality (~E7.0); conditional Tr4 erythroid cells show failure to fully differentiate, diminished proliferation, decreased Alad and Alas2 (heme biosynthesis genes), and increased Cdkn1c expression.","method":"Conditional knockout mouse model, erythroid differentiation analysis, gene expression analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout in congenic background with defined molecular targets identified (Alad, Alas2, Cdkn1c), multiple phenotypes characterized","pmids":["29018082"],"is_preprint":false},{"year":2018,"finding":"TR4 promotes ccRCC metastasis via the miR-32-5p/TR4/HGF/Met/MMP2-MMP9 axis; miR-32-5p suppresses TR4 protein by binding to the 3'UTR of TR4 mRNA; TR4 transcriptionally regulates HGF via direct binding to TR4RE on the HGF promoter; in vivo mouse model confirmed pathway.","method":"miR target binding assay (3'UTR), ChIP/reporter for TR4-HGF, invasion/migration assay, xenograft mouse model","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct TR4 binding to HGF promoter plus miR-3'UTR targeting plus in vivo model, single lab","pmids":["29396852"],"is_preprint":false},{"year":2018,"finding":"TR4 promotes ccRCC vasculogenic mimicry (VM) and metastasis via miR490-3p/vimentin (VIM) signaling; TR4 decreases miR-490-3p by binding TR4-REs on its promoter, leading to increased VIM expression; preclinical mouse sub-renal capsule model confirmed the pathway.","method":"ChIP/reporter for TR4 on miR-490-3p promoter, 3'UTR targeting assay, VM assay, xenograft mouse model","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct TR4 binding at promoter plus downstream miRNA-target validation plus in vivo confirmation, single lab","pmids":["29973687"],"is_preprint":false},{"year":2019,"finding":"TR4 modulates lncTASR (ENST00000600671.1) expression via transcriptional regulation; lncTASR increases AXL protein expression by enhancing AXL mRNA stability, conferring sunitinib resistance in RCC; bexarotene (a retinoid) antagonizes TR4, increasing sunitinib sensitivity.","method":"TR4 knockdown/overexpression, reporter assay, RNA stability assay, drug sensitivity assay, xenograft mouse model","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transcriptional regulation plus mRNA stability mechanism plus in vivo validation, single lab","pmids":["31501521"],"is_preprint":false},{"year":2020,"finding":"Bexarotene directly interacts with TR4 ligand-binding domain, induces a conformational change in TR4-LBD secondary structure, and promotes TR4 translocation from nucleus to cytoplasm, thereby reducing TR4 binding to TR4RE on the POMC promoter and suppressing POMC expression and ACTH secretion; validated in vivo in mouse corticotroph tumor model.","method":"In silico virtual screening, structural modeling, TR4-LBD conformational assay, nuclear/cytoplasmic fractionation, ChIP/reporter assay, xenograft mouse model","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct LBD binding with conformational assay plus localization tracking plus functional POMC reporter plus in vivo model, single lab","pmids":["33491272"],"is_preprint":false},{"year":2020,"finding":"TR4 transcriptionally increases RNA-binding protein QKI expression; increased QKI elevates circZEB1, which sponges miR-141-3p to increase ZEB1 expression, conferring prostate cancer radioresistance; metformin combined with radiation suppresses PCa via this pathway.","method":"siRNA knockdown, reporter assay, RT-PCR, xenograft mouse model","journal":"Cancer letters","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pathway dissection but relies on circRNA sponge mechanism; TR4's direct action only on QKI transcription, no direct binding evidence reported in abstract","pmids":["32768524"],"is_preprint":false},{"year":2023,"finding":"NR2C2 activates NF-κB signaling in macrophages by binding DR elements in the promoter of the Nfκb gene, promoting expression of IL-1β and IL-6, and thereby inducing testicular inflammation (orchitis) and inhibiting spermatogonial proliferation.","method":"RNA interference in primary macrophages and RAW264.7, ChIP (implied by DR binding assay), inflammatory cytokine measurement, spermatogonia proliferation assay, LPS-induced orchitis mouse model","journal":"Reproduction (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo mouse model plus in vitro mechanistic dissection with promoter binding and functional cytokine readout, single lab","pmids":["37427695"],"is_preprint":false},{"year":2024,"finding":"TR4 and BCL11A competitively bind in vitro to distinct but overlapping sequences at the -117 position of the γ-globin promoter; TR4 represses γ-globin transcription and fetal hemoglobin in vivo independently of BCL11A; genome-wide ChIP shows BCL11A but not TR4 binds γ-globin promoters at statistically significant frequency in vivo, while both bind the locus control region.","method":"In vitro binding competition assay, in vivo functional studies, ChIP-seq","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro binding competition plus in vivo functional epistasis plus genome-wide ChIP-seq, multiple orthogonal methods resolving a prior discrepancy","pmids":["39393056"],"is_preprint":false}],"current_model":"NR2C2 (TR4) is a nuclear orphan receptor that functions primarily as a transcriptional repressor or activator depending on the DNA response element context (repression via DR1/DR3/DR5, activation via DR4): it forms homodimers and TR2/TR4 heterodimers via its LBD (helix 10), binds direct repeat hormone response elements, and recruits distinct corepressor complexes (DNMT1, NuRD, LSD1/CoREST, HDAC3, TIF1β) to silence embryonic and fetal β-globin genes in adult erythroid cells; its transcriptional activity is regulated by ligands (retinoids, polyunsaturated fatty acid metabolites, thiazolidinediones that bind an autorepressed LBD), post-translational modifications (acetylation of DBD lysines K175/K176 by ARA55 reduces DNA binding; SIRT7-mediated deacetylation of DDB1 protects TR4 from CUL4B/DDB1/DCAF1 ubiquitin-mediated degradation; MAPK-mediated phosphorylation enhances POMC transactivation), and selective corepressors (TIP27, TRA16); in vivo, TR4 is required for cerebellar development, gluconeogenesis (via PEPCK), lipid homeostasis (via CD36, apoE/C-I/C-II, fatty acid synthesis genes), mitochondrial function (via NDUFAF1/complex I), DNA damage responses (via GADD45A, ATM, CSB), erythroid maturation, and inflammatory signaling (via NF-κB in macrophages)."},"narrative":{"mechanistic_narrative":"NR2C2 (TR4) is a nuclear orphan receptor that binds direct-repeat hormone response elements as a homodimer or as a heterodimer with the related receptor TR2, exerting element-dependent bidirectional transcriptional control—repressing DR1/DR3/DR5 targets while activating DR4 targets [PMID:9115296, PMID:9737983, PMID:10347174]. Heterodimerization with TR2 is mediated by the ligand-binding domain, requiring three leucines on helix 10 of TR2, and TR2/TR4 complexes show enhanced repressive activity on shared elements [PMID:9737983]. Crystallography of the LBD reveals an autorepressed conformation in which helix 10 and the AF-2 helix occupy the ligand pocket and cofactor surface; retinol and retinoic acid bind this pocket to drive coactivator recruitment and activation [PMID:21068381], and TR4 is responsive to additional lipophilic ligands including polyunsaturated fatty acid metabolites and a mycobacterial keto-mycolic acid [PMID:19666541, PMID:24907344]. In erythroid cells, TR2/TR4 function as the DNA-binding core of the DRED corepressor complex that occupies DR1 sites in embryonic ε- and fetal γ-globin promoters and recruits epigenetic silencing machinery (DNMT1, NuRD, LSD1/CoREST, HDAC3, TIF1β) to stage-selectively repress these genes; loss of TR2/TR4 delays embryonic globin silencing while forced expression can paradoxically induce γ-globin and elevate fetal hemoglobin in adult cells [PMID:12093744, PMID:17431400, PMID:21670149, PMID:22042865]. TR4 additionally represses GATA1 through a conserved enhancer DR element and is independently required for erythroid maturation and heme biosynthesis gene expression [PMID:17974920, PMID:29018082]. Beyond erythropoiesis, TR4 directly transactivates metabolic and stress-response targets identified through knockout-mouse and promoter studies—PEPCK in gluconeogenesis, CD36 and apolipoprotein genes in lipid handling, NDUFAF1 in mitochondrial complex I assembly, and GADD45A/ATM in DNA-damage responses [PMID:12954636, PMID:17827404, PMID:19666541, PMID:21622535, PMID:22396141]. TR4 activity is tuned by post-translational modification and selective cofactors: ARA55-promoted acetylation of DBD lysines K175/K176 reduces DNA binding, SIRT7-driven DDB1 deacetylation protects TR4 from CUL4B/DDB1/DCAF1-mediated degradation, and the selective repressors TIP27 and TRA16 bind the LBD/DBD to block transactivation [PMID:21515881, PMID:28623141, PMID:15302918, PMID:12486131].","teleology":[{"year":1994,"claim":"Establishing that TR4 is a distinct nuclear receptor defined the molecular class of factor under study and predicted a DNA-binding, ligand-regulated transcriptional role.","evidence":"cDNA cloning and sequence analysis from human and rat tissues","pmids":["8016112"],"confidence":"High","gaps":["No ligand or target gene identified at this stage","No functional or structural characterization"]},{"year":1997,"claim":"Quantitative binding and reporter assays answered whether TR4 acts as activator or repressor, revealing element-dependent bidirectional regulation—repressing DR1 targets but activating DR4 promoters.","evidence":"EMSA, Scatchard analysis, and CAT reporter assays on DR1 and DR4 elements","pmids":["9006963","9115296"],"confidence":"Medium","gaps":["Cofactors mediating the opposite outcomes not identified","Single-lab reporter data without endogenous target validation"]},{"year":1998,"claim":"Demonstrating that TR4 forms TR2/TR4 heterodimers via LBD helix 10 leucines, competes with PPARα for DNA and coactivators, and feeds back on retinoic acid signaling established its mode of intersecting with other receptor pathways.","evidence":"Yeast/mammalian two-hybrid, pull-down, EMSA, GFP imaging, and reporter assays with mutagenesis","pmids":["9737983","9556573","9593676"],"confidence":"High","gaps":["Physiological context of receptor crosstalk untested in vivo","Cell-type specificity of competition not defined"]},{"year":1999,"claim":"Conformational analyses on DR3 versus DR4 elements answered how a single receptor produces opposite transcriptional outputs, showing element-induced TR4 conformations select distinct coregulators.","evidence":"EMSA, antibody supershift, proteolytic footprinting, and reporter assays","pmids":["10347174"],"confidence":"Medium","gaps":["Specific coregulators recruited to each conformation not identified","Structural basis inferred indirectly"]},{"year":2002,"claim":"Purifying the endogenous DRED complex and showing TR2/TR4 occupy embryonic globin DR1 sites identified the receptor's central role in developmental hemoglobin switching.","evidence":"Biochemical purification with mass spectrometry, EMSA, and transgenic mice","pmids":["12093744"],"confidence":"High","gaps":["Full corepressor composition not yet defined","Mechanism of stage-selectivity unresolved"]},{"year":2002,"claim":"Selective cofactors and direct receptor inhibition were defined: TRA16 and (later) TIP27 repress TR4 via its LBD/DBD, and TR4 directly inhibits ER dimerization, mapping protein-level control of TR4 output.","evidence":"Two-hybrid, Co-IP, GST pull-down, EMSA, and proliferation assays","pmids":["12486131","11844790","15302918"],"confidence":"Medium","gaps":["Physiological relevance of TRA16/TIP27 repression in vivo unestablished","Tissue distribution of these cofactors unclear"]},{"year":2003,"claim":"Identification of apoE/apoC and HBV core promoter targets showed TR4 directly regulates lipoprotein metabolism and can repress viral transcription through receptor crosstalk, with knockout mice confirming the apoE link in vivo.","evidence":"Gel shift, reporter assays, Co-IP, and TR4 knockout mice","pmids":["12954636","12522137"],"confidence":"High","gaps":["Quantitative contribution of TR4 to systemic lipid homeostasis not isolated","HNF4α interaction interface not mapped"]},{"year":2007,"claim":"Genetic mouse models resolved the in vivo developmental function of TR2/TR4 as stage-selective repressors of embryonic globins and direct repressors of GATA1, anchoring the in vitro DRED model in physiology.","evidence":"Null and transgenic mice, dominant-negative TR4, ChIP, EMSA, and CD34+ knockdown","pmids":["17431400","17974920"],"confidence":"High","gaps":["Paradoxical γ-globin induction by forced expression mechanistically unexplained","Relative contributions of TR2 vs TR4 not separated"]},{"year":2007,"claim":"Knockout phenotypes established TR4 as a direct transcriptional driver of gluconeogenesis via PEPCK, extending its role into systemic glucose metabolism.","evidence":"Knockout mice, EMSA, ChIP, reporter, RNAi, and glucose production assays","pmids":["17827404"],"confidence":"High","gaps":["Upstream signals controlling hepatic TR4 activity unclear","Coregulators at the PEPCK promoter unidentified"]},{"year":2009,"claim":"Showing TR4 transactivates CD36 in response to fatty acid metabolites and TZDs defined TR4 as a lipid/fatty-acid sensor controlling foam-cell formation.","evidence":"Knockout mice, EMSA, ChIP, siRNA/rescue, and foam-cell and reporter assays","pmids":["19666541"],"confidence":"High","gaps":["Endogenous high-affinity ligand not definitively established","Direct ligand binding not measured in this study"]},{"year":2010,"claim":"The LBD crystal structure answered why TR4 is an 'orphan' with low basal activity, revealing an autorepressed pocket that retinoids relieve to enable coactivator recruitment.","evidence":"X-ray crystallography, coactivator recruitment, reporter assays, and mutagenesis","pmids":["21068381"],"confidence":"High","gaps":["Physiological endogenous ligand not crystallized","Conformational dynamics in solution not captured"]},{"year":2010,"claim":"Comprehensive metabolic knockout studies established that TR4 loss confers resistance to metabolic syndrome, integrating TR4 into whole-body lipid and energy homeostasis.","evidence":"Knockout mice, expression profiling, and metabolic and hepatocyte rescue studies","pmids":["20864514"],"confidence":"High","gaps":["Tissue-specific contributions not dissected","Direct vs indirect target regulation not fully separated"]},{"year":2010,"claim":"Genome-wide ChIP-seq tested whether the in vitro DR1 model captures TR4 chromatin occupancy, revealing most sites lack DR1 and many are co-bound with ELK4, indicating recruitment via protein-protein interactions.","evidence":"TR4 and ELK4 ChIP-seq with motif and co-occupancy analysis in four cell types","pmids":["21126370"],"confidence":"Medium","gaps":["Direct TR4-ELK4 interaction not biochemically demonstrated","Functional output at DR1-less sites untested"]},{"year":2011,"claim":"Defining the epigenetic corepressors recruited by TR2/TR4 at embryonic globin promoters explained the molecular silencing mechanism and showed multiple distinct corepressor complexes operate.","evidence":"ChIP, biotin-tag complex purification, mass spectrometry, Co-IP, and differentiation assays","pmids":["21670149"],"confidence":"High","gaps":["Determinants of complex selection at specific promoters unclear","Order of corepressor assembly not defined"]},{"year":2011,"claim":"Knockout studies extended TR4 function into mitochondrial complex I assembly (via NDUFAF1), oxidative-stress/DNA-damage defense (GADD45A), and bone formation (osteocalcin), broadening its role as a stress- and differentiation-responsive activator.","evidence":"Knockout mice, ATP/complex I assays, ChIP, EMSA, reporter, and rescue experiments","pmids":["21622535","22396141","21521714","22676849"],"confidence":"High","gaps":["Signals inducing TR4 in stress contexts incompletely defined","Direct vs indirect regulation of some targets uncertain"]},{"year":2011,"claim":"Discovery that ARA55 promotes acetylation of TR4 DBD lysines K175/K176 to reduce DNA binding established post-translational modification as a direct lever on TR4 activity.","evidence":"Site-directed mutagenesis, Co-IP, DNA-binding, and reporter assays","pmids":["21515881"],"confidence":"Medium","gaps":["The responsible acetyltransferase not identified","In vivo relevance of acetylation untested"]},{"year":2011,"claim":"Forced TR2/TR4 expression in a sickle-cell mouse model demonstrated therapeutic-relevant induction of fetal hemoglobin, linking the repressor mechanism to hemoglobinopathy intervention.","evidence":"Humanized sickle-cell transgenic mice with hematological readouts","pmids":["22042865"],"confidence":"High","gaps":["Mechanism of paradoxical γ-globin activation unresolved","Translation to human therapy untested"]},{"year":2013,"claim":"Demonstrating MAPK-phosphorylation-enhanced TR4 activation of POMC in corticotroph tumors revealed a phosphorylation-regulated oncogenic transactivation function.","evidence":"Overexpression/knockdown, reporter assays with MAPK inhibitors, and xenograft model","pmids":["23653479"],"confidence":"High","gaps":["MAPK phosphorylation site(s) not mapped","Upstream activating signals in tumors unclear"]},{"year":2014,"claim":"ITC and structural identification of a mycobacterial keto-mycolic acid as a TR4 ligand established that TR4 senses pathogen-derived lipids to drive foamy macrophage and granuloma formation.","evidence":"Transactivation, ITC, TLC/NMR, and granuloma models","pmids":["24907344"],"confidence":"Medium","gaps":["Structural basis of the keto-MA-LBD interaction not solved","Generality across mycolic acid species untested"]},{"year":2014,"claim":"Multiple cancer studies dissected context-dependent TR4 roles—tumor suppressor via ATM in prostate cancer initiation versus pro-metastatic via CCL2 and stemness/chemoresistance axes—revealing dual oncogenic and suppressive functions.","evidence":"Knockout and xenograft mouse models, ChIP, reporter, and rescue/neutralization experiments","pmids":["24583925","24975468","23609451"],"confidence":"Medium","gaps":["What dictates suppressor vs promoter context unresolved","Most downstream axes shown in single labs"]},{"year":2014,"claim":"Identification of pyruvate carboxylase as a direct TR4 target connected TR4 transcriptional activity to de novo fatty acid synthesis in adipocytes.","evidence":"Reporter, ChIP, siRNA epistasis, and radiolabeled carbon incorporation assays","pmids":["25240193"],"confidence":"Medium","gaps":["In vivo contribution to lipogenesis not isolated","Coregulators at PC promoter unidentified"]},{"year":2015,"claim":"Conditional adult-bone-marrow knockout confirmed that loss of TR2/TR4 occupancy de-represses embryonic globins and is required for terminal erythroid maturation, separating developmental silencing from cell viability.","evidence":"Conditional knockout mice, in vitro differentiation, and ChIP","pmids":["25561507"],"confidence":"High","gaps":["Mechanism of maturation requirement not fully defined","Redundancy between TR2 and TR4 not resolved here"]},{"year":2017,"claim":"Two findings defined TR4 protein-level regulation and a non-redundant erythroid role: SIRT7/DDB1 deacetylation protects TR4 from CUL4B-mediated degradation, and TR4-specific knockout causes embryonic lethality with heme-biosynthesis defects.","evidence":"Co-IP, K1121R mutagenesis, qPCR, and congenic conditional knockout mice","pmids":["28623141","29018082"],"confidence":"High","gaps":["E3 ligase regulation of TR4 in physiological contexts incompletely mapped","TR4-specific vs TR2/TR4-shared targets only partly resolved"]},{"year":2018,"claim":"ccRCC studies established TR4-centered miRNA/oncogene axes (miR-32-5p/HGF/Met and miR-490-3p/vimentin) driving metastasis and vasculogenic mimicry, expanding TR4's regulatory reach to non-coding RNA networks.","evidence":"3'UTR targeting, ChIP/reporter at TR4REs, invasion assays, and xenograft models","pmids":["29396852","29973687"],"confidence":"Medium","gaps":["Single-lab pathway dissections","Clinical generalizability untested"]},{"year":2020,"claim":"Bexarotene was shown to directly bind the TR4 LBD, induce a conformational change and nuclear-to-cytoplasmic relocalization, providing a pharmacological strategy to inhibit TR4-driven POMC/ACTH output.","evidence":"Virtual screening, conformational and fractionation assays, ChIP/reporter, and xenograft model","pmids":["33491272"],"confidence":"Medium","gaps":["Binding pose not solved by crystallography","Specificity over related receptors not fully tested"]},{"year":2023,"claim":"Identification of NR2C2-driven NF-κB activation in macrophages linked the receptor to inflammatory cytokine production and testicular inflammation, defining an immune-regulatory function.","evidence":"RNAi in primary macrophages, DR-element binding, cytokine assays, and LPS-orchitis mouse model","pmids":["37427695"],"confidence":"Medium","gaps":["Direct ChIP occupancy at the Nfkb promoter only implied","Generality beyond testicular macrophages untested"]},{"year":2024,"claim":"Resolving the long-standing question of how TR4 represses γ-globin, this work showed TR4 and BCL11A compete at the -117 γ-globin promoter region but TR4 acts independently of BCL11A and binds the locus control region genome-wide.","evidence":"In vitro binding competition, in vivo functional epistasis, and ChIP-seq","pmids":["39393056"],"confidence":"High","gaps":["Precise in vivo TR4 binding site at γ-globin promoter still ambiguous","Mechanistic interplay with BCL11A at LCR not fully defined"]},{"year":null,"claim":"The identity of the physiological endogenous ligand(s) that relieve TR4 autorepression in vivo, and the rules determining whether TR4 activates or represses a given locus, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No endogenous high-affinity ligand defined despite retinoid/fatty-acid binding","Determinants of element-dependent activation vs repression not mechanistically settled","Rules governing tissue-specific corepressor recruitment unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,11,17,19,20,21,24]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,2,9,18,27,48]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[20,21,33]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,12,15,45]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[11,17,19,24]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[19,20,22,25,36]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[24]}],"complexes":["DRED (TR2/TR4) repressor complex"],"partners":["TR2","BCL11A","ELK4","SP1","ER","HNF4A","TIP27","TRA16"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P49116","full_name":"Nuclear receptor subfamily 2 group C member 2","aliases":["Orphan nuclear receptor TAK1","Orphan nuclear receptor TR4","Testicular receptor 4"],"length_aa":596,"mass_kda":65.4,"function":"Orphan nuclear receptor that can act as a repressor or activator of transcription. An important repressor of nuclear receptor signaling pathways such as retinoic acid receptor, retinoid X, vitamin D3 receptor, thyroid hormone receptor and estrogen receptor pathways. May regulate gene expression during the late phase of spermatogenesis. Together with NR2C1, forms the core of the DRED (direct repeat erythroid-definitive) complex that represses embryonic and fetal globin transcription including that of GATA1. Binds to hormone response elements (HREs) consisting of two 5'-AGGTCA-3' half site direct repeat consensus sequences. Plays a fundamental role in early embryonic development and embryonic stem cells. Required for normal spermatogenesis and cerebellum development. Appears to be important for neurodevelopmentally regulated behavior (By similarity). Activates transcriptional activity of LHCG. Antagonist of PPARA-mediated transactivation","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P49116/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NR2C2","classification":"Not Classified","n_dependent_lines":25,"n_total_lines":1208,"dependency_fraction":0.020695364238410598},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NR2C2","total_profiled":1310},"omim":[{"mim_id":"619211","title":"HIPPOCALCIN-LIKE 4; HPCAL4","url":"https://www.omim.org/entry/619211"},{"mim_id":"617962","title":"ZINC FINGER PROTEIN 827; ZNF827","url":"https://www.omim.org/entry/617962"},{"mim_id":"613363","title":"DYNEIN, CYTOPLASMIC 2, INTERMEDIATE CHAIN 2; DYNC2I2","url":"https://www.omim.org/entry/613363"},{"mim_id":"606681","title":"NUCLEAR RECEPTOR-BINDING SET DOMAIN PROTEIN 1; NSD1","url":"https://www.omim.org/entry/606681"},{"mim_id":"606246","title":"JAZF ZINC FINGER 1; JAZF1","url":"https://www.omim.org/entry/606246"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NR2C2"},"hgnc":{"alias_symbol":["TAK1","TR2R1","hTAK1"],"prev_symbol":["TR4"]},"alphafold":{"accession":"P49116","domains":[{"cath_id":"3.30.50.10","chopping":"125-185","consensus_level":"medium","plddt":96.138,"start":125,"end":185},{"cath_id":"1.10.565.10","chopping":"312-320_353-590","consensus_level":"high","plddt":84.4281,"start":312,"end":590}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49116","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49116-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49116-F1-predicted_aligned_error_v6.png","plddt_mean":65.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NR2C2","jax_strain_url":"https://www.jax.org/strain/search?query=NR2C2"},"sequence":{"accession":"P49116","fasta_url":"https://rest.uniprot.org/uniprotkb/P49116.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49116/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49116"}},"corpus_meta":[{"pmid":"16319225","id":"PMC_16319225","title":"Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16319225","citation_count":189,"is_preprint":false},{"pmid":"22544925","id":"PMC_22544925","title":"Mycobacterium tuberculosis modulates macrophage lipid-sensing nuclear receptors PPARγ and TR4 for survival.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22544925","citation_count":161,"is_preprint":false},{"pmid":"8016112","id":"PMC_8016112","title":"Human and rat TR4 orphan receptors specify a subclass of the steroid receptor superfamily.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8016112","citation_count":147,"is_preprint":false},{"pmid":"21670149","id":"PMC_21670149","title":"Nuclear receptors TR2 and TR4 recruit multiple epigenetic transcriptional corepressors that associate specifically with the embryonic β-type globin promoters in differentiated adult erythroid cells.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21670149","citation_count":107,"is_preprint":false},{"pmid":"12093744","id":"PMC_12093744","title":"An embryonic/fetal beta-type globin gene repressor contains a nuclear receptor TR2/TR4 heterodimer.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12093744","citation_count":98,"is_preprint":false},{"pmid":"20864514","id":"PMC_20864514","title":"Nuclear orphan receptor TAK1/TR4-deficient mice are protected against obesity-linked inflammation, hepatic steatosis, and insulin resistance.","date":"2010","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/20864514","citation_count":92,"is_preprint":false},{"pmid":"19666541","id":"PMC_19666541","title":"TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19666541","citation_count":90,"is_preprint":false},{"pmid":"17431400","id":"PMC_17431400","title":"Embryonic and fetal beta-globin gene repression by the orphan nuclear receptors, TR2 and TR4.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17431400","citation_count":86,"is_preprint":false},{"pmid":"15302918","id":"PMC_15302918","title":"TIP27: a novel repressor of the nuclear orphan receptor TAK1/TR4.","date":"2004","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15302918","citation_count":85,"is_preprint":false},{"pmid":"12361719","id":"PMC_12361719","title":"Recent advances in the TR2 and TR4 orphan receptors of the nuclear receptor superfamily.","date":"2002","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12361719","citation_count":79,"is_preprint":false},{"pmid":"31513293","id":"PMC_31513293","title":"Fusaric acid instigates the invasion of banana by Fusarium oxysporum f. sp. cubense TR4.","date":"2019","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/31513293","citation_count":67,"is_preprint":false},{"pmid":"21068381","id":"PMC_21068381","title":"The orphan nuclear receptor TR4 is a vitamin A-activated nuclear receptor.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21068381","citation_count":63,"is_preprint":false},{"pmid":"17827404","id":"PMC_17827404","title":"Loss of TR4 orphan nuclear receptor reduces phosphoenolpyruvate carboxykinase-mediated gluconeogenesis.","date":"2007","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/17827404","citation_count":63,"is_preprint":false},{"pmid":"9556573","id":"PMC_9556573","title":"Regulation of peroxisome proliferator-activated receptor alpha-induced transactivation by the nuclear orphan receptor TAK1/TR4.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9556573","citation_count":59,"is_preprint":false},{"pmid":"23653479","id":"PMC_23653479","title":"Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23653479","citation_count":56,"is_preprint":false},{"pmid":"24907344","id":"PMC_24907344","title":"Mycobacterium tuberculosis keto-mycolic acid and macrophage nuclear receptor TR4 modulate foamy biogenesis in granulomas: a case of a heterologous and noncanonical ligand-receptor pair.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24907344","citation_count":56,"is_preprint":false},{"pmid":"9593676","id":"PMC_9593676","title":"Negative feedback control of the retinoid-retinoic acid/retinoid X receptor pathway by the human TR4 orphan receptor, a member of the steroid receptor superfamily.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9593676","citation_count":53,"is_preprint":false},{"pmid":"9006963","id":"PMC_9006963","title":"Induction of the intronic enhancer of the human ciliary neurotrophic factor receptor (CNTFRalpha) gene by the TR4 orphan receptor. A member of steroid receptor superfamily.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9006963","citation_count":52,"is_preprint":false},{"pmid":"9115296","id":"PMC_9115296","title":"Identification of direct repeat 4 as a positive regulatory element for the human TR4 orphan receptor. A modulator for the thyroid hormone target genes.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9115296","citation_count":52,"is_preprint":false},{"pmid":"23609451","id":"PMC_23609451","title":"Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23609451","citation_count":50,"is_preprint":false},{"pmid":"17974920","id":"PMC_17974920","title":"The TR2 and TR4 orphan nuclear receptors repress Gata1 transcription.","date":"2007","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17974920","citation_count":45,"is_preprint":false},{"pmid":"11844790","id":"PMC_11844790","title":"Modulation of estrogen receptor-mediated transactivation by orphan receptor TR4 in MCF-7 cells.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11844790","citation_count":43,"is_preprint":false},{"pmid":"22042865","id":"PMC_22042865","title":"Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22042865","citation_count":42,"is_preprint":false},{"pmid":"10347174","id":"PMC_10347174","title":"Differential regulation of direct repeat 3 vitamin D3 and direct repeat 4 thyroid hormone signaling pathways by the human TR4 orphan receptor.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10347174","citation_count":41,"is_preprint":false},{"pmid":"9737983","id":"PMC_9737983","title":"A novel nuclear receptor heterodimerization pathway mediated by orphan receptors TR2 and TR4.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9737983","citation_count":39,"is_preprint":false},{"pmid":"24975468","id":"PMC_24975468","title":"TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.","date":"2014","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24975468","citation_count":38,"is_preprint":false},{"pmid":"29396852","id":"PMC_29396852","title":"Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.","date":"2018","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29396852","citation_count":38,"is_preprint":false},{"pmid":"12954636","id":"PMC_12954636","title":"Disruption of TR4 orphan nuclear receptor reduces the expression of liver apolipoprotein E/C-I/C-II gene cluster.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12954636","citation_count":36,"is_preprint":false},{"pmid":"28527578","id":"PMC_28527578","title":"TR2 and TR4 Orphan Nuclear Receptors: An Overview.","date":"2017","source":"Current topics in developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/28527578","citation_count":35,"is_preprint":false},{"pmid":"29973687","id":"PMC_29973687","title":"TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/29973687","citation_count":35,"is_preprint":false},{"pmid":"32768524","id":"PMC_32768524","title":"Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity.","date":"2020","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/32768524","citation_count":34,"is_preprint":false},{"pmid":"25623427","id":"PMC_25623427","title":"Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.","date":"2015","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25623427","citation_count":34,"is_preprint":false},{"pmid":"21521714","id":"PMC_21521714","title":"Premature aging with impaired oxidative stress defense in mice lacking TR4.","date":"2011","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21521714","citation_count":33,"is_preprint":false},{"pmid":"25980442","id":"PMC_25980442","title":"TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGFβR2/p-Smad3 signals.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25980442","citation_count":32,"is_preprint":false},{"pmid":"30518750","id":"PMC_30518750","title":"NR2C2-uORF targeting UCA1-miR-627-5p-NR2C2 feedback loop to regulate the malignant behaviors of glioma cells.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30518750","citation_count":29,"is_preprint":false},{"pmid":"24583925","id":"PMC_24583925","title":"TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system.","date":"2014","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/24583925","citation_count":29,"is_preprint":false},{"pmid":"9694834","id":"PMC_9694834","title":"A bidirectional regulation between the TR2/TR4 orphan receptors (TR2/TR4) and the ciliary neurotrophic factor (CNTF) signaling pathway.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9694834","citation_count":29,"is_preprint":false},{"pmid":"27109382","id":"PMC_27109382","title":"miRNA-133a attenuates lipid accumulation via TR4-CD36 pathway in macrophages.","date":"2016","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/27109382","citation_count":28,"is_preprint":false},{"pmid":"24702179","id":"PMC_24702179","title":"Minireview: Pathophysiological roles of the TR4 nuclear receptor: lessons learned from mice lacking TR4.","date":"2014","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/24702179","citation_count":28,"is_preprint":false},{"pmid":"21126370","id":"PMC_21126370","title":"Genome-wide binding of the orphan nuclear receptor TR4 suggests its general role in fundamental biological processes.","date":"2010","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/21126370","citation_count":28,"is_preprint":false},{"pmid":"20393820","id":"PMC_20393820","title":"Altered cerebellar development in nuclear receptor TAK1/ TR4 null mice is associated with deficits in GLAST(+) glia, alterations in social behavior, motor learning, startle reactivity, and microglia.","date":"2010","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20393820","citation_count":27,"is_preprint":false},{"pmid":"28623141","id":"PMC_28623141","title":"Sirtuin 7-dependent deacetylation of DDB1 regulates the expression of nuclear receptor TR4.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28623141","citation_count":25,"is_preprint":false},{"pmid":"22676849","id":"PMC_22676849","title":"Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis.","date":"2012","source":"Reproductive biology and endocrinology : RB&E","url":"https://pubmed.ncbi.nlm.nih.gov/22676849","citation_count":25,"is_preprint":false},{"pmid":"31501521","id":"PMC_31501521","title":"Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31501521","citation_count":24,"is_preprint":false},{"pmid":"12522137","id":"PMC_12522137","title":"Suppression of hepatitis B virus core promoter by the nuclear orphan receptor TR4.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12522137","citation_count":23,"is_preprint":false},{"pmid":"30473219","id":"PMC_30473219","title":"Role and mechanism of miR-4778-3p and its targets NR2C2 and Med19 in cervical cancer radioresistance.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30473219","citation_count":22,"is_preprint":false},{"pmid":"25561507","id":"PMC_25561507","title":"Compound loss of function of nuclear receptors Tr2 and Tr4 leads to induction of murine embryonic β-type globin genes.","date":"2015","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25561507","citation_count":22,"is_preprint":false},{"pmid":"31548557","id":"PMC_31548557","title":"Identification of Fusarium oxysporum f. sp. cubense tropical race 4 (Foc TR4) responsive miRNAs in banana root.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31548557","citation_count":22,"is_preprint":false},{"pmid":"33116641","id":"PMC_33116641","title":"Long Noncoding RNA CDKN2B-AS1 Facilitates Lung Cancer Development Through Regulating miR-378b/NR2C2.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33116641","citation_count":21,"is_preprint":false},{"pmid":"29449527","id":"PMC_29449527","title":"TR4 nuclear receptor suppresses HCC cell invasion via downregulating the EphA2 expression.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29449527","citation_count":21,"is_preprint":false},{"pmid":"18418664","id":"PMC_18418664","title":"The roles of testicular orphan nuclear receptor 4 (TR4) in cerebellar development.","date":"2008","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18418664","citation_count":21,"is_preprint":false},{"pmid":"19618297","id":"PMC_19618297","title":"Activation of TR4 orphan nuclear receptor gene promoter by cAMP/PKA and C/EBP signaling.","date":"2009","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/19618297","citation_count":20,"is_preprint":false},{"pmid":"12486131","id":"PMC_12486131","title":"Identification of a novel testicular orphan receptor-4 (TR4)-associated protein as repressor for the selective suppression of TR4-mediated transactivation.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12486131","citation_count":20,"is_preprint":false},{"pmid":"21622535","id":"PMC_21622535","title":"Mice lacking TR4 nuclear receptor develop mitochondrial myopathy with deficiency in complex I.","date":"2011","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/21622535","citation_count":19,"is_preprint":false},{"pmid":"10814836","id":"PMC_10814836","title":"Expression of the orphan receptor TR4 during brain development of the rat.","date":"2000","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/10814836","citation_count":18,"is_preprint":false},{"pmid":"15670754","id":"PMC_15670754","title":"Induction of apolipoprotein E expression by TR4 orphan nuclear receptor via 5' proximal promoter region.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15670754","citation_count":18,"is_preprint":false},{"pmid":"33996257","id":"PMC_33996257","title":"Testicular orphan receptor 4 (TR4) promotes papillary thyroid cancer invasion via activating circ-FNLA/miR-149-5p/MMP9 signaling.","date":"2021","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/33996257","citation_count":17,"is_preprint":false},{"pmid":"31748715","id":"PMC_31748715","title":"Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31748715","citation_count":17,"is_preprint":false},{"pmid":"22396141","id":"PMC_22396141","title":"Deficiency in TR4 nuclear receptor abrogates Gadd45a expression and increases cytotoxicity induced by ionizing radiation.","date":"2012","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/22396141","citation_count":16,"is_preprint":false},{"pmid":"27050071","id":"PMC_27050071","title":"TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growth.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27050071","citation_count":15,"is_preprint":false},{"pmid":"21515881","id":"PMC_21515881","title":"Increased acetylation in the DNA-binding domain of TR4 nuclear receptor by the coregulator ARA55 leads to suppression of TR4 transactivation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21515881","citation_count":15,"is_preprint":false},{"pmid":"17706948","id":"PMC_17706948","title":"Abnormal cerebellar cytoarchitecture and impaired inhibitory signaling in adult mice lacking TR4 orphan nuclear receptor.","date":"2007","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/17706948","citation_count":15,"is_preprint":false},{"pmid":"26074876","id":"PMC_26074876","title":"TR4 Nuclear Receptor Different Roles in Prostate Cancer Progression.","date":"2015","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26074876","citation_count":14,"is_preprint":false},{"pmid":"10201524","id":"PMC_10201524","title":"Induction of TR4 orphan receptor by retinoic acid in human HaCaT keratinocytes.","date":"1999","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/10201524","citation_count":14,"is_preprint":false},{"pmid":"11714637","id":"PMC_11714637","title":"The nuclear orphan receptor TR4 promotes proliferation of myeloid progenitor cells.","date":"2001","source":"Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/11714637","citation_count":14,"is_preprint":false},{"pmid":"8661150","id":"PMC_8661150","title":"New variants of the human and rat nuclear hormone receptor, TR4: expression and chromosomal localization of the human gene.","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8661150","citation_count":14,"is_preprint":false},{"pmid":"16839558","id":"PMC_16839558","title":"SmTR2/4, a Schistosoma mansoni homologue of TR2/TR4 orphan nuclear receptor.","date":"2006","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/16839558","citation_count":14,"is_preprint":false},{"pmid":"24623743","id":"PMC_24623743","title":"Differential roles of PPARγ vs TR4 in prostate cancer and metabolic diseases.","date":"2014","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24623743","citation_count":13,"is_preprint":false},{"pmid":"34956884","id":"PMC_34956884","title":"miR-616-5p Promotes Invasion and Migration of Bladder Cancer via Downregulating NR2C2 Expression.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34956884","citation_count":13,"is_preprint":false},{"pmid":"9421416","id":"PMC_9421416","title":"Cloning of rabbit TR4 and its bone cell-specific activity to suppress estrogen receptor-mediated transactivation.","date":"1998","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9421416","citation_count":13,"is_preprint":false},{"pmid":"25859557","id":"PMC_25859557","title":"TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells.","date":"2015","source":"Oncoscience","url":"https://pubmed.ncbi.nlm.nih.gov/25859557","citation_count":13,"is_preprint":false},{"pmid":"15381082","id":"PMC_15381082","title":"Modulation of the retinoic acid-induced cell apoptosis and differentiation by the human TR4 orphan nuclear receptor.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15381082","citation_count":13,"is_preprint":false},{"pmid":"29018082","id":"PMC_29018082","title":"The orphan nuclear receptor TR4 regulates erythroid cell proliferation and maturation.","date":"2017","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/29018082","citation_count":12,"is_preprint":false},{"pmid":"37427695","id":"PMC_37427695","title":"NR2C2 of macrophages promotes inflammation via NF-κB in LPS-induced orchitis in mice.","date":"2023","source":"Reproduction (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37427695","citation_count":12,"is_preprint":false},{"pmid":"21918225","id":"PMC_21918225","title":"Testicular nuclear receptor 4 (TR4) regulates UV light-induced responses via Cockayne syndrome B protein-mediated transcription-coupled DNA repair.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21918225","citation_count":12,"is_preprint":false},{"pmid":"36938065","id":"PMC_36938065","title":"Disentangling the resistant mechanism of Fusarium wilt TR4 interactions with different cultivars and its elicitor application.","date":"2023","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/36938065","citation_count":12,"is_preprint":false},{"pmid":"9704574","id":"PMC_9704574","title":"TR4 orphan receptor crosstalks to chicken ovalbumin upstream protein-transcription factor and thyroid hormone receptor to induce the transcriptional activity of the human immunodeficiency virus type 1 long-terminal repeat.","date":"1998","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/9704574","citation_count":12,"is_preprint":false},{"pmid":"17054912","id":"PMC_17054912","title":"Transactivation of the proximal promoter of human oxytocin gene by TR4 orphan receptor.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17054912","citation_count":12,"is_preprint":false},{"pmid":"30755103","id":"PMC_30755103","title":"Di(2-ethylhexyl)phthalate induces reproductive toxicity via JAZF1/TR4 pathway and oxidative stress in pubertal male rats.","date":"2019","source":"Toxicology and industrial health","url":"https://pubmed.ncbi.nlm.nih.gov/30755103","citation_count":11,"is_preprint":false},{"pmid":"33050283","id":"PMC_33050283","title":"Secretome Analysis of the Banana Fusarium Wilt Fungi Foc R1 and Foc TR4 Reveals a New Effector OASTL Required for Full Pathogenicity of Foc TR4 in Banana.","date":"2020","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33050283","citation_count":11,"is_preprint":false},{"pmid":"27084994","id":"PMC_27084994","title":"Di-(2-ethylhexyl) phthalate induces apoptosis of GC-2spd cells via TR4/Bcl-2 pathway.","date":"2016","source":"Environmental toxicology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27084994","citation_count":11,"is_preprint":false},{"pmid":"16414012","id":"PMC_16414012","title":"Stage dependent and androgen inductive expression of orphan receptor TR4 in rat testis.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16414012","citation_count":10,"is_preprint":false},{"pmid":"8612486","id":"PMC_8612486","title":"Splice variants of rat TR4 orphan receptor: differential expression of novel sequences in the 5'-untranslated region and C-terminal domain.","date":"1996","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8612486","citation_count":10,"is_preprint":false},{"pmid":"24811540","id":"PMC_24811540","title":"Biased, non-equivalent gene-proximal and -distal binding motifs of orphan nuclear receptor TR4 in primary human erythroid cells.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24811540","citation_count":9,"is_preprint":false},{"pmid":"38790192","id":"PMC_38790192","title":"Roles of Nuclear Orphan Receptors TR2 and TR4 during Hematopoiesis.","date":"2024","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/38790192","citation_count":8,"is_preprint":false},{"pmid":"21995792","id":"PMC_21995792","title":"The roles of testicular nuclear receptor 4 (TR4) in male fertility-priapism and sexual behavior defects in TR4 knockout mice.","date":"2011","source":"Reproductive biology and endocrinology : RB&E","url":"https://pubmed.ncbi.nlm.nih.gov/21995792","citation_count":8,"is_preprint":false},{"pmid":"16452526","id":"PMC_16452526","title":"Expression of orphan receptors TR2, TR3, TR4, and p53 in heat-treated testis of cynomolgus monkeys (Macaca fascicularis).","date":"2006","source":"Journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/16452526","citation_count":8,"is_preprint":false},{"pmid":"33072258","id":"PMC_33072258","title":"Beta-catenin inhibits TR4-mediated lipid accumulation in 3T3-L1 adipocytes via induction of Slug.","date":"2020","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/33072258","citation_count":8,"is_preprint":false},{"pmid":"17645519","id":"PMC_17645519","title":"Collective repression of the hepatitis B virus enhancer II by human TR4 and TR2 orphan receptors.","date":"2007","source":"Hepatology research : the official journal of the Japan Society of Hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/17645519","citation_count":8,"is_preprint":false},{"pmid":"31223310","id":"PMC_31223310","title":"Immunohistochemical Study of NR2C2, BTG2, TBX19, and CDK2 Expression in 31 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas.","date":"2019","source":"International journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31223310","citation_count":7,"is_preprint":false},{"pmid":"26762765","id":"PMC_26762765","title":"CREB/GSK-3β signaling pathway regulates the expression of TR4 orphan nuclear receptor gene.","date":"2016","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26762765","citation_count":7,"is_preprint":false},{"pmid":"33491272","id":"PMC_33491272","title":"Targeting the TR4 nuclear receptor with antagonist bexarotene can suppress the proopiomelanocortin signalling in AtT-20 cells.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33491272","citation_count":7,"is_preprint":false},{"pmid":"25925376","id":"PMC_25925376","title":"The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status.","date":"2015","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/25925376","citation_count":7,"is_preprint":false},{"pmid":"7522976","id":"PMC_7522976","title":"Induction of membrane ruffling by growth factors in morphologically TPA-resistant Balb/c3T3 TR4 cells.","date":"1994","source":"Cell structure and function","url":"https://pubmed.ncbi.nlm.nih.gov/7522976","citation_count":7,"is_preprint":false},{"pmid":"7928419","id":"PMC_7928419","title":"The ER-TR4 monoclonal antibody recognizes murine thymic epithelial cells (type 1) and inhibits their capacity to interact with immature thymocytes: immuno-electron microscopic and functional studies.","date":"1994","source":"Histochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7928419","citation_count":7,"is_preprint":false},{"pmid":"33803818","id":"PMC_33803818","title":"Weed-Associated Fungal Endophytes as Biocontrol Agents of Fusarium oxysporum f. sp. cubense TR4 in Cavendish Banana.","date":"2021","source":"Journal of fungi (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/33803818","citation_count":7,"is_preprint":false},{"pmid":"37380939","id":"PMC_37380939","title":"Iron necessity for chlamydospore germination in Fusarium oxysporum f. sp. cubense TR4.","date":"2023","source":"Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37380939","citation_count":4,"is_preprint":false},{"pmid":"25240193","id":"PMC_25240193","title":"TR4 promotes fatty acid synthesis in 3T3-L1 adipocytes by activation of pyruvate carboxylase expression.","date":"2014","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/25240193","citation_count":4,"is_preprint":false},{"pmid":"35851144","id":"PMC_35851144","title":"De novo synthesis of ferrichrome by Fusarium oxysporum f. sp. cubense TR4 in response to iron starvation.","date":"2022","source":"Fungal biology","url":"https://pubmed.ncbi.nlm.nih.gov/35851144","citation_count":4,"is_preprint":false},{"pmid":"39393056","id":"PMC_39393056","title":"TR4 and BCL11A repress γ-globin transcription via independent mechanisms.","date":"2024","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/39393056","citation_count":3,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48048,"output_tokens":11629,"usd":0.15929,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":23090,"output_tokens":7372,"usd":0.149875,"stage2_stop_reason":"end_turn"},"total_usd":0.309165,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"TR4 (NR2C2) was identified as a member of the steroid receptor superfamily, cloned from human and rat hypothalamus/prostate/testis, encoding a 615 (human) or 596 (rat) amino acid protein with high homology to TR2, establishing TR2 and TR4 as a unique subfamily within the nuclear receptor superfamily.\",\n      \"method\": \"cDNA cloning, sequence analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — original cloning paper with sequence determination and structural characterization, independently replicated across species\",\n      \"pmids\": [\"8016112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"TR4 binds with high affinity (Kd = 0.066 nM) to a conserved DR1 hormone response element (CNTFR-DR1) in the 5th intron of the CNTFRα gene and induces its enhancer activity in a dose-dependent manner, identifying CNTFRα as the first neural-specific gene transactivated by TR4.\",\n      \"method\": \"EMSA, reporter gene (CAT) assay, in situ hybridization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA plus reporter assay in single lab, two orthogonal methods\",\n      \"pmids\": [\"9006963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"TR4 binds DR4-HRE with strong affinity (Kd = 2 nM) and induces transcription from DR4-containing promoters (including rat α-myosin heavy chain and S14), in contrast to its repressive activity on DR1-HRE targets, demonstrating element-dependent bidirectional transcriptional regulation.\",\n      \"method\": \"EMSA, Scatchard analysis, CAT reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA with quantitative binding plus functional reporter assay, single lab\",\n      \"pmids\": [\"9115296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TR4 represses RA-induced transactivation via a negative feedback mechanism by binding DR1 and DR5 elements (RAR and RXR response elements) with higher affinity than RAR/RXR, and RA treatment increases TR4 mRNA and protein levels in F9 cells, establishing a negative feedback loop.\",\n      \"method\": \"EMSA, CAT reporter assay, Western blot, Northern blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (EMSA, reporter, protein/mRNA), single lab\",\n      \"pmids\": [\"9593676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TAK1/TR4 binds DR1 response elements as a homodimer with greatest affinity for AGGTCAAAGGTCA, represses PPARα-mediated transactivation by competing with PPARα/RXR for PPRE binding, and also competes with PPARα for the co-activator RIP-140 (shown by two-hybrid analysis); TR4 does not heterodimerize with PPARα or RXRα.\",\n      \"method\": \"Site selection analysis, gel shift assay, cell transfection/reporter assay, two-hybrid analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (binding, reporter, protein interaction), single lab\",\n      \"pmids\": [\"9556573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TR2 and TR4 preferentially form heterodimers in solution and on DR5-containing DNA elements; the dimerization is mediated by the ligand-binding domains with three leucine residues on helix 10 of TR2 being critical; coexpression of TR2 and TR4 exerts stronger repressive activity on DR5-reporter than either receptor alone.\",\n      \"method\": \"Yeast two-hybrid, mammalian two-hybrid, pull-down assay, EMSA, GFP intracellular localization tracking, reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods including in vitro pulldown, two-hybrid systems, EMSA, and live-cell imaging with mutagenesis of critical residues\",\n      \"pmids\": [\"9737983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TR4 crosstalks with COUP-TF1 and thyroid hormone receptor (TRα1) to potentiate HIV-LTR transcriptional activity, while TR4 alone has no effect on HIV-LTR; TR2 does not show this crosstalk activity, demonstrating TR4-specific functional interaction with other nuclear receptors.\",\n      \"method\": \"Gel retardation assay (EMSA), CAT reporter assay, transient transfection\",\n      \"journal\": \"Endocrine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, reporter assay only, no direct protein interaction demonstrated\",\n      \"pmids\": [\"9704574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"TR4 suppresses estrogen receptor-mediated transactivation in bone cells (osteosarcoma cell lines) but not in kidney or breast cancer cells, establishing a bone cell-specific repressor activity of TR4 on ER signaling.\",\n      \"method\": \"Transient transfection assay, Northern blot\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, functional reporter in cell lines only, no direct protein interaction assay\",\n      \"pmids\": [\"9421416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"CNTF increases TR4 expression and enhances TR4 DNA-binding capacity; TR2 expression is also induced by CNTF and TR2 induces CNTFRα transcriptional activity via CNTFR-I5 DR element, establishing bidirectional regulation between TR2/TR4 and the CNTF signaling pathway.\",\n      \"method\": \"EMSA, reporter assay, in situ hybridization, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA plus reporter plus in vivo expression, single lab\",\n      \"pmids\": [\"9694834\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"TR4 binds DR3VDRE with high affinity (Kd = 1.32 nM) and represses vitamin D3 target gene (25-hydroxyvitamin D3 24-hydroxylase) expression, in contrast to its induction of DR4T3RE target genes; distinct TR4 conformations when bound to DR3VDRE vs. DR4T3RE (shown by antibody supershift and proteolytic analysis) allow recruitment of different coregulators.\",\n      \"method\": \"EMSA, cell transfection/reporter assay, antibody supershift, proteolytic analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative binding, functional assay, conformational analysis using multiple techniques, single lab\",\n      \"pmids\": [\"10347174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TR4 directly interacts with estrogen receptor (ER) via protein-protein interaction, inhibits ER homodimerization, and prevents ER binding to estrogen response elements, resulting in suppression of ER target genes (cyclin D1, pS2) and inhibition of ER-mediated cell proliferation in MCF-7 cells.\",\n      \"method\": \"EMSA, GST pull-down assay, reporter assay, stable transfection, cell proliferation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — GST pulldown demonstrating direct interaction plus EMSA for functional consequence, single lab, two orthogonal methods\",\n      \"pmids\": [\"11844790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The DRED (direct repeat erythroid-definitive) repressor complex contains TR2 and TR4 as a heterodimer that binds DR1 sites in human embryonic ε-globin and fetal γ-globin gene promoters; DRED is a ~540 kDa complex; TR2/TR4 binding is reduced by an HPFH mutation in the DR1 site; forced transgenic TR2/TR4 expression reduces embryonic εy-globin transcription.\",\n      \"method\": \"Biochemical purification, mass spectrometry/sequence determination, EMSA, transgenic mouse model\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — purification and sequencing of endogenous complex, EMSA, and in vivo transgenic validation, multiple orthogonal methods\",\n      \"pmids\": [\"12093744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"A novel TR4-associated protein TRA16 (16 kDa, 139 amino acids, nuclear localization) selectively represses TR4-mediated transactivation by interacting with TR4 DNA-binding and ligand-binding domains; TRA16 reduces TR4 binding to TR4RE without inhibiting TR4 homodimerization; TRA16 blocks TR4-LBD interaction; the repression is TR4-selective (minimal effect on AR, GR, PR).\",\n      \"method\": \"Mammalian two-hybrid, Co-IP, EMSA, reporter assay, confocal microscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus two-hybrid plus EMSA plus functional reporter, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"12486131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TR4 binds to a DR1 element (TR4RE-HBV) in the HBV core promoter and suppresses pre-core and core mRNA transcription; TR4 suppresses HBV core promoter by repressing HNF4α-mediated transactivation through protein-protein interaction (TR4 N- and C-terminal regions required), without inhibiting HNF4α DNA binding.\",\n      \"method\": \"EMSA, luciferase reporter assay, primer extension, co-immunoprecipitation, deletion/domain analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple complementary methods including EMSA, reporter, and protein interaction, single lab\",\n      \"pmids\": [\"12522137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TR4 induces apoE gene expression via a TR4 response element in the hepatic control region 15 kb downstream of the apoE gene, and also regulates apoC-I and apoC-II expression via the same hepatic control region TR4RE; TR4 forms a complex with Sp1 for synergistic apoE induction via a proximal promoter DR0 element; TR4 knockout mice show significantly reduced serum apoE protein and liver apoE mRNA.\",\n      \"method\": \"Gel shift assay, luciferase reporter, TR4 knockout mice, quantitative analysis of serum/mRNA levels\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vitro binding/reporter complemented by in vivo knockout mouse validation, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"12954636\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"TIP27, a novel 27 kDa zinc finger protein, interacts specifically with the TR4 ligand-binding domain (helix 3 to C-terminus) via its TAK1-interaction domain (residues Asp39–Lys79) and functions as a selective repressor of TR4/DR1-dependent transactivation without inhibiting TR4 homodimerization or DNA binding, suggesting repression via interference with co-activator recruitment.\",\n      \"method\": \"Yeast two-hybrid, mammalian two-hybrid, pull-down assay, confocal microscopy, reporter assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast and mammalian two-hybrid plus pull-down plus localization, single lab\",\n      \"pmids\": [\"15302918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"TR4 induces apoE expression in multiple cell lines via binding to a DR0 element (TR4RE-DR0-apoE at -303 to -292 bp) in the apoE 5' proximal promoter, and forms a complex with Sp1 to synergistically induce apoE expression.\",\n      \"method\": \"Gel shift assay, luciferase reporter assay, RT-PCR, Western blot\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, overlapping with prior study (PMID 12954636), no in vivo validation\",\n      \"pmids\": [\"15670754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TR2 and TR4 are stage-selective repressors of embryonic β-type globin genes in vivo: Tr2 and Tr4 null mutant mice show delayed silencing of εy and βh1 globins in definitive erythroid cells; dominant-negative TR4 activates human ε-globin in both primitive and definitive erythroid cells but activates γ-globin only in definitive cells; forced TR2/TR4 expression causes precocious ε-globin repression but paradoxically induces γ-globin in definitive erythroid cells.\",\n      \"method\": \"Knockout and transgenic mouse models, gene expression analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic in vivo mouse models (null mutants, dominant-negative, transgenic overexpression) with defined gene-specific phenotypes\",\n      \"pmids\": [\"17431400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TR2 and TR4 directly repress Gata1/GATA1 transcription in murine and human erythroid progenitor cells through an evolutionarily conserved DR element in the GATA1 hematopoietic enhancer; TR2/TR4 binds this site in vitro and in vivo; mutation of the DR element elevates Gata1 promoter activity and reduces responsiveness to cotransfected TR2/TR4.\",\n      \"method\": \"Knockout and transgenic mouse models, ChIP, EMSA, reporter assay, shRNA knockdown in human CD34+ cells\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP in vivo, EMSA in vitro, mutagenesis of binding site, multiple genetic models\",\n      \"pmids\": [\"17974920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TR4 knockout mice show significantly reduced PEPCK expression and impaired gluconeogenesis; TR4 transactivates the PEPCK promoter by direct binding to a TR4RE at -451 to -439 bp; TR4 knockdown in hepatocytes reduces glucose production; ectopic TR4 expression increases PEPCK expression and hepatic glucose production.\",\n      \"method\": \"Knockout mice, EMSA, ChIP, luciferase reporter assay, siRNA/RNAi in hepatocytes, glucose production assay\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro binding/reporter validated by in vivo knockout mouse plus siRNA, multiple orthogonal methods\",\n      \"pmids\": [\"17827404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TR4 induces CD36 expression transcriptionally by binding to a TR4 response element in the CD36 5' promoter; this transactivation is enhanced by polyunsaturated fatty acids (omega-3/-6) and their metabolites (15-HETE, 13-HODE) and by rosiglitazone (TZD); TR4 knockout mice show reduced CD36 expression and foam cell formation; TR4 acts as a fatty acid sensor.\",\n      \"method\": \"TR4 knockout mice, EMSA, ChIP, siRNA knockdown, cDNA rescue, foam cell formation assay, reporter assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro binding (EMSA, ChIP) plus in vivo knockout plus siRNA/rescue experiments, multiple orthogonal methods\",\n      \"pmids\": [\"19666541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Crystal structure of the TR4 ligand-binding domain reveals an autorepressed conformation: the LBP is filled by the C-terminal half of helix 10 and the AF-2 helix occupies the cofactor binding site; retinol and retinoic acid promote TR4 to recruit coactivators and activate TR4-regulated reporters; mutations disrupting cofactor binding, dimerization, or ligand binding substantially reduce TR4 transcriptional activity.\",\n      \"method\": \"X-ray crystallography, coactivator recruitment assay, reporter assay, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional mutagenesis and ligand binding assays, multiple orthogonal methods\",\n      \"pmids\": [\"21068381\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TAK1/TR4 knockout mice are resistant to age- and high-fat-diet-induced metabolic syndrome; TR4 deficiency reduces hepatic triglyceride levels, lipid accumulation in adipose tissue, adipose inflammation, and insulin resistance; TR4 regulates lipogenic genes (Cidea, Cidec, Mogat1, CD36) in liver; TR4 knockout mice show increased energy expenditure.\",\n      \"method\": \"TR4 knockout mice, gene expression profiling, histochemical/biochemical analysis, metabolic studies, primary hepatocyte rescue experiments\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — comprehensive knockout mouse study with multiple metabolic phenotypic readouts and gene expression profiling, single lab but extensive characterization\",\n      \"pmids\": [\"20864514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Genome-wide ChIP-seq of TR4 in 4 human cell types shows that less than 30% of TR4 binding sites contain a DR1 motif (derived from in vitro studies), and ~30% of TR4 sites are co-occupied by the ETS factor ELK4 at sites lacking DR1, suggesting TR4 can be recruited to chromatin via protein-protein interaction with ETS factors.\",\n      \"method\": \"ChIP-seq, bioinformatics/motif analysis, ELK4 ChIP-seq\",\n      \"journal\": \"BMC genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide ChIP-seq with co-occupancy analysis, single lab, correlation-based finding for ELK4 interaction\",\n      \"pmids\": [\"21126370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TR2 and TR4 recruit multiple epigenetic corepressor complexes (DNMT1, NuRD, LSD1/CoREST, HDAC3, TIF1β) specifically to embryonic β-globin promoters but not the adult β-globin promoter in adult erythroid cells; at least four distinct TR2/TR4 molecular complexes exist; upon terminal erythroid differentiation, corepressors dissociate from adult but not embryonic globin promoters.\",\n      \"method\": \"ChIP, biotin-tag purification of TR2/TR4 complexes, mass spectrometry, co-immunoprecipitation, erythroid differentiation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — endogenous complex purification with MS identification plus reciprocal Co-IP plus ChIP, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"21670149\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TR4 knockout mice develop mitochondrial myopathy with reduced complex I activity, decreased mitochondrial ATP production, and increased serum lactate; TR4 transcriptionally regulates the complex I assembly factor NDUFAF1; restoration of TR4 or NDUFAF1 in TR4-/- myoblasts rescues mitochondrial ATP generation and complex I activity.\",\n      \"method\": \"TR4 knockout mice, histology, ATP production assay, complex I activity assay, qPCR, promoter study, rescue experiments\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knockout plus in vitro biochemical assays plus promoter studies plus rescue experiments, multiple orthogonal methods\",\n      \"pmids\": [\"21622535\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TR4 knockout mice show premature aging with increased genome instability and defective oxidative stress defense; TR4-/- MEFs show rapid growth arrest and reduced resistance to oxidative stress and DNA damage; restoring TR4 or adding antioxidant NAC reduces DNA damage in TR4-/- MEFs; TR4 loss alters genes in DNA damage response and anti-ROS pathways.\",\n      \"method\": \"TR4 knockout mice, MEF culture, DNA damage assays, qPCR array, NAC rescue, oxidative stress assays\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo knockout plus in vitro rescue, multiple phenotypic readouts, single lab\",\n      \"pmids\": [\"21521714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ARA55 functions as a corepressor of TR4 by enhancing acetylation of TR4 at conserved lysine residues K175 and K176 in the DNA-binding domain via recruiting histone acetyltransferase activity, thereby significantly reducing TR4 DNA-binding activity and suppressing TR4 transactivation.\",\n      \"method\": \"Mutation analysis, co-IP, reporter assay, DNA binding assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis of specific acetylation sites combined with functional reporter and DNA binding assays, single lab\",\n      \"pmids\": [\"21515881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Forced TR2/TR4 expression in sickle cell disease model mice increases fetal hemoglobin (HbF) from 7.6% to 18.6% of total hemoglobin, increases hematocrit, reduces reticulocytes, and reduces hepatosplenomegaly, demonstrating that TR2/TR4 can paradoxically induce γ-globin in adult definitive erythroid cells.\",\n      \"method\": \"Transgenic mouse model (humanized sickle cell model), hemoglobin analysis, hematological measurements, histology\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo transgenic mouse model with multiple hematological readouts validating mechanism\",\n      \"pmids\": [\"22042865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TR4 transcriptionally regulates GADD45A through TR4 response elements located in intron 3 of the GADD45A gene; TR4 deficiency abrogates Gadd45a expression and increases IR-induced cell death; IR increases TR4 expression in normal but not TR4 knockdown cells.\",\n      \"method\": \"ChIP, luciferase reporter assay, qPCR, shRNA knockdown, TR4 knockout MEFs, irradiation assay\",\n      \"journal\": \"Cellular & molecular biology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter with mutagenesis plus functional cell-death assay, single lab\",\n      \"pmids\": [\"22396141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TR4 knockout mice develop osteoporosis with reduced osteoblast activity; TR4 directly binds the promoter region of osteocalcin and induces its transcription; osteoblast progenitor cells from TR4 knockout mice show reduced differentiation and calcification with decreased expression of ALP, type I collagen α1, osteocalcin, PTH, and PTHR.\",\n      \"method\": \"TR4 knockout mice, bone analysis, primary osteoblast culture, alkaline phosphatase/alizarin red staining, luciferase reporter, ChIP, EMSA\",\n      \"journal\": \"Reproductive biology and endocrinology : RB&E\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knockout mouse plus in vitro direct binding (ChIP, EMSA) plus reporter assays, multiple orthogonal methods\",\n      \"pmids\": [\"22676849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TR4 is overexpressed in human corticotroph tumors and transcriptionally activates proopiomelanocortin (POMC) via binding a DR1 response element in the POMC promoter; this activation is enhanced by MAPK-mediated TR4 phosphorylation; forced TR4 overexpression increases ACTH secretion, cellular proliferation, and tumor invasion in vitro and promotes corticotroph tumor growth in vivo.\",\n      \"method\": \"Overexpression/knockdown in cell lines, reporter assay, luciferase assay with MAPK inhibitors, xenograft mouse model, ACTH/corticosterone measurement\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic dissection in vitro with DR1 binding plus MAPK modification plus in vivo tumor model validation, multiple methods\",\n      \"pmids\": [\"23653479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TR4 promotes prostate cancer CD133+ stem/progenitor cell chemoresistance via a TR4→Oct4→IL1Ra axis; TR4 knockdown reduces Oct4 expression which reduces IL1Ra expression; restoring Oct4 or IL1Ra in TR4-knockdown cells reverses chemosensitivity.\",\n      \"method\": \"siRNA/lentiviral knockdown, drug sensitivity (IC50) assay, apoptosis assay, neutralization experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis-style rescue experiments establishing pathway order, single lab\",\n      \"pmids\": [\"23609451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Mycobacterium tuberculosis keto-mycolic acid acts as a heterologous ligand for TR4, binding with energetically favorable thermodynamics (isothermal titration calorimetry); this keto-MA–TR4 interaction induces foamy macrophage formation and granuloma development in vitro and in vivo.\",\n      \"method\": \"Transactivation assay, promoter reporter assay, TLC, NMR, isothermal titration calorimetry, in vitro and in vivo granuloma models\",\n      \"journal\": \"Journal of immunology (Baltimore, Md. : 1950)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — direct ligand-binding assay (ITC) plus functional transactivation plus structural identification (NMR/TLC), single lab\",\n      \"pmids\": [\"24907344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TR4 promotes prostate cancer metastasis by transcriptionally upregulating CCL2; ChIP and luciferase assays confirmed TR4 binding to the CCL2 promoter; CCR2 antagonist reverses TR4-enhanced PCa cell migration/invasion in vitro and PCa metastasis in orthotopic mouse model.\",\n      \"method\": \"siRNA/cDNA overexpression, migration/invasion assay, ChIP, luciferase assay, orthotopic xenograft mouse model\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter plus in vivo mouse model, single lab\",\n      \"pmids\": [\"24975468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TR4 functions as a tumor suppressor during PCa initiation by transcriptionally regulating ATM expression; TR4 knockdown increases DNA damage and reduces ATM levels; ATM restoration partially reverses TR4-siRNA-induced tumorigenesis; three mouse models support TR4's suppressor role.\",\n      \"method\": \"TR4 knockout mouse models, siRNA knockdown, cell transformation assay, ATM rescue experiment, IHC, qPCR\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple mouse models plus rescue experiment, single lab\",\n      \"pmids\": [\"24583925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TR4 directly binds the pyruvate carboxylase (PC) promoter via a TR4 responsive element and increases PC gene expression and activity in 3T3-L1 adipocytes; TR4-mediated fatty acid synthesis requires PC activity, as siRNA knockdown of PC or PC inhibition abolishes TR4-enhanced fatty acid synthesis.\",\n      \"method\": \"Luciferase reporter assay, ChIP (implied by direct binding), siRNA, PC activity assay, radiolabeled carbon incorporation assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — binding/reporter plus biochemical activity assay plus siRNA epistasis, single lab\",\n      \"pmids\": [\"25240193\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Compound conditional knockout of Tr2 and Tr4 in adult bone marrow cells leads to induced expression of embryonic εy and βh1 globins, confirms loss of TR2/TR4 occupancy at embryonic globin promoters and impairs co-occupancy by interacting corepressors; TR2/TR4 function is also required for terminal erythroid cell maturation.\",\n      \"method\": \"Conditional knockout mouse model, in vitro bone marrow differentiation, globin expression analysis, ChIP\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout (avoiding embryonic lethality) with ChIP demonstrating direct occupancy loss, extends prior genetic evidence\",\n      \"pmids\": [\"25561507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TR4 increases prostate cancer invasion by decreasing miR-373-3p expression, which activates TGFβR2/p-Smad3 signaling; in vivo orthotopic mouse model confirmed TR4-increased PCa metastasis is mediated through decreased miR-373-3p.\",\n      \"method\": \"Overexpression/knockdown, invasion assay, miRNA expression analysis, orthotopic xenograft mouse model\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — correlative pathway dissection without direct binding evidence for TR4 on miR-373-3p promoter, single lab\",\n      \"pmids\": [\"25980442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TR4 transcriptionally regulates TIMP-1 and MMP2; knockdown of TR4 in PCa cells suppresses macrophage infiltration via increasing TIMP-1 with decreased MMP2; TIMP-1 neutralizing antibody reverses the effect, establishing TR4→MMP2/TIMP-1 axis in macrophage-mediated PCa invasion.\",\n      \"method\": \"siRNA knockdown, macrophage migration assay, invasion assay, TIMP-1 neutralization, IHC of patient samples\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — indirect mechanistic evidence without direct TR4 binding to target gene promoters, single lab\",\n      \"pmids\": [\"25623427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SIRT7 deacetylates DDB1 at Lys1121, reducing its binding to DCAF1, thereby attenuating CUL4B/DDB1/DCAF1 E3 ubiquitin ligase activity and increasing TR4 protein levels; K1121R-DDB1 (deacetylation mimic) shows reduced DCAF1 binding and elevated TR4 and TR4 target gene expression (Cd36, Cidea, Cidec, Pparg1).\",\n      \"method\": \"Co-IP (SIRT7-DDB1 interaction), site-directed mutagenesis (K1121R), overexpression, Western blot, qPCR\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction demonstrated, mutagenesis validates mechanism, functional target gene readout, single lab\",\n      \"pmids\": [\"28623141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TR4 plays a distinct individual role in erythroid development beyond TR2/TR4 redundancy: Tr4 null mutation in congenic C57BL/6 background causes early embryonic lethality (~E7.0); conditional Tr4 erythroid cells show failure to fully differentiate, diminished proliferation, decreased Alad and Alas2 (heme biosynthesis genes), and increased Cdkn1c expression.\",\n      \"method\": \"Conditional knockout mouse model, erythroid differentiation analysis, gene expression analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout in congenic background with defined molecular targets identified (Alad, Alas2, Cdkn1c), multiple phenotypes characterized\",\n      \"pmids\": [\"29018082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TR4 promotes ccRCC metastasis via the miR-32-5p/TR4/HGF/Met/MMP2-MMP9 axis; miR-32-5p suppresses TR4 protein by binding to the 3'UTR of TR4 mRNA; TR4 transcriptionally regulates HGF via direct binding to TR4RE on the HGF promoter; in vivo mouse model confirmed pathway.\",\n      \"method\": \"miR target binding assay (3'UTR), ChIP/reporter for TR4-HGF, invasion/migration assay, xenograft mouse model\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct TR4 binding to HGF promoter plus miR-3'UTR targeting plus in vivo model, single lab\",\n      \"pmids\": [\"29396852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TR4 promotes ccRCC vasculogenic mimicry (VM) and metastasis via miR490-3p/vimentin (VIM) signaling; TR4 decreases miR-490-3p by binding TR4-REs on its promoter, leading to increased VIM expression; preclinical mouse sub-renal capsule model confirmed the pathway.\",\n      \"method\": \"ChIP/reporter for TR4 on miR-490-3p promoter, 3'UTR targeting assay, VM assay, xenograft mouse model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct TR4 binding at promoter plus downstream miRNA-target validation plus in vivo confirmation, single lab\",\n      \"pmids\": [\"29973687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TR4 modulates lncTASR (ENST00000600671.1) expression via transcriptional regulation; lncTASR increases AXL protein expression by enhancing AXL mRNA stability, conferring sunitinib resistance in RCC; bexarotene (a retinoid) antagonizes TR4, increasing sunitinib sensitivity.\",\n      \"method\": \"TR4 knockdown/overexpression, reporter assay, RNA stability assay, drug sensitivity assay, xenograft mouse model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transcriptional regulation plus mRNA stability mechanism plus in vivo validation, single lab\",\n      \"pmids\": [\"31501521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Bexarotene directly interacts with TR4 ligand-binding domain, induces a conformational change in TR4-LBD secondary structure, and promotes TR4 translocation from nucleus to cytoplasm, thereby reducing TR4 binding to TR4RE on the POMC promoter and suppressing POMC expression and ACTH secretion; validated in vivo in mouse corticotroph tumor model.\",\n      \"method\": \"In silico virtual screening, structural modeling, TR4-LBD conformational assay, nuclear/cytoplasmic fractionation, ChIP/reporter assay, xenograft mouse model\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct LBD binding with conformational assay plus localization tracking plus functional POMC reporter plus in vivo model, single lab\",\n      \"pmids\": [\"33491272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TR4 transcriptionally increases RNA-binding protein QKI expression; increased QKI elevates circZEB1, which sponges miR-141-3p to increase ZEB1 expression, conferring prostate cancer radioresistance; metformin combined with radiation suppresses PCa via this pathway.\",\n      \"method\": \"siRNA knockdown, reporter assay, RT-PCR, xenograft mouse model\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pathway dissection but relies on circRNA sponge mechanism; TR4's direct action only on QKI transcription, no direct binding evidence reported in abstract\",\n      \"pmids\": [\"32768524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NR2C2 activates NF-κB signaling in macrophages by binding DR elements in the promoter of the Nfκb gene, promoting expression of IL-1β and IL-6, and thereby inducing testicular inflammation (orchitis) and inhibiting spermatogonial proliferation.\",\n      \"method\": \"RNA interference in primary macrophages and RAW264.7, ChIP (implied by DR binding assay), inflammatory cytokine measurement, spermatogonia proliferation assay, LPS-induced orchitis mouse model\",\n      \"journal\": \"Reproduction (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo mouse model plus in vitro mechanistic dissection with promoter binding and functional cytokine readout, single lab\",\n      \"pmids\": [\"37427695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TR4 and BCL11A competitively bind in vitro to distinct but overlapping sequences at the -117 position of the γ-globin promoter; TR4 represses γ-globin transcription and fetal hemoglobin in vivo independently of BCL11A; genome-wide ChIP shows BCL11A but not TR4 binds γ-globin promoters at statistically significant frequency in vivo, while both bind the locus control region.\",\n      \"method\": \"In vitro binding competition assay, in vivo functional studies, ChIP-seq\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro binding competition plus in vivo functional epistasis plus genome-wide ChIP-seq, multiple orthogonal methods resolving a prior discrepancy\",\n      \"pmids\": [\"39393056\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NR2C2 (TR4) is a nuclear orphan receptor that functions primarily as a transcriptional repressor or activator depending on the DNA response element context (repression via DR1/DR3/DR5, activation via DR4): it forms homodimers and TR2/TR4 heterodimers via its LBD (helix 10), binds direct repeat hormone response elements, and recruits distinct corepressor complexes (DNMT1, NuRD, LSD1/CoREST, HDAC3, TIF1β) to silence embryonic and fetal β-globin genes in adult erythroid cells; its transcriptional activity is regulated by ligands (retinoids, polyunsaturated fatty acid metabolites, thiazolidinediones that bind an autorepressed LBD), post-translational modifications (acetylation of DBD lysines K175/K176 by ARA55 reduces DNA binding; SIRT7-mediated deacetylation of DDB1 protects TR4 from CUL4B/DDB1/DCAF1 ubiquitin-mediated degradation; MAPK-mediated phosphorylation enhances POMC transactivation), and selective corepressors (TIP27, TRA16); in vivo, TR4 is required for cerebellar development, gluconeogenesis (via PEPCK), lipid homeostasis (via CD36, apoE/C-I/C-II, fatty acid synthesis genes), mitochondrial function (via NDUFAF1/complex I), DNA damage responses (via GADD45A, ATM, CSB), erythroid maturation, and inflammatory signaling (via NF-κB in macrophages).\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NR2C2 (TR4) is a nuclear orphan receptor that binds direct-repeat hormone response elements as a homodimer or as a heterodimer with the related receptor TR2, exerting element-dependent bidirectional transcriptional control—repressing DR1/DR3/DR5 targets while activating DR4 targets [#2, #5, #9]. Heterodimerization with TR2 is mediated by the ligand-binding domain, requiring three leucines on helix 10 of TR2, and TR2/TR4 complexes show enhanced repressive activity on shared elements [#5]. Crystallography of the LBD reveals an autorepressed conformation in which helix 10 and the AF-2 helix occupy the ligand pocket and cofactor surface; retinol and retinoic acid bind this pocket to drive coactivator recruitment and activation [#21], and TR4 is responsive to additional lipophilic ligands including polyunsaturated fatty acid metabolites and a mycobacterial keto-mycolic acid [#20, #33]. In erythroid cells, TR2/TR4 function as the DNA-binding core of the DRED corepressor complex that occupies DR1 sites in embryonic ε- and fetal γ-globin promoters and recruits epigenetic silencing machinery (DNMT1, NuRD, LSD1/CoREST, HDAC3, TIF1β) to stage-selectively repress these genes; loss of TR2/TR4 delays embryonic globin silencing while forced expression can paradoxically induce γ-globin and elevate fetal hemoglobin in adult cells [#11, #17, #24, #28]. TR4 additionally represses GATA1 through a conserved enhancer DR element and is independently required for erythroid maturation and heme biosynthesis gene expression [#18, #41]. Beyond erythropoiesis, TR4 directly transactivates metabolic and stress-response targets identified through knockout-mouse and promoter studies—PEPCK in gluconeogenesis, CD36 and apolipoprotein genes in lipid handling, NDUFAF1 in mitochondrial complex I assembly, and GADD45A/ATM in DNA-damage responses [#14, #19, #20, #25, #29]. TR4 activity is tuned by post-translational modification and selective cofactors: ARA55-promoted acetylation of DBD lysines K175/K176 reduces DNA binding, SIRT7-driven DDB1 deacetylation protects TR4 from CUL4B/DDB1/DCAF1-mediated degradation, and the selective repressors TIP27 and TRA16 bind the LBD/DBD to block transactivation [#27, #40, #15, #12].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing that TR4 is a distinct nuclear receptor defined the molecular class of factor under study and predicted a DNA-binding, ligand-regulated transcriptional role.\",\n      \"evidence\": \"cDNA cloning and sequence analysis from human and rat tissues\",\n      \"pmids\": [\"8016112\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No ligand or target gene identified at this stage\", \"No functional or structural characterization\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Quantitative binding and reporter assays answered whether TR4 acts as activator or repressor, revealing element-dependent bidirectional regulation—repressing DR1 targets but activating DR4 promoters.\",\n      \"evidence\": \"EMSA, Scatchard analysis, and CAT reporter assays on DR1 and DR4 elements\",\n      \"pmids\": [\"9006963\", \"9115296\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cofactors mediating the opposite outcomes not identified\", \"Single-lab reporter data without endogenous target validation\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating that TR4 forms TR2/TR4 heterodimers via LBD helix 10 leucines, competes with PPARα for DNA and coactivators, and feeds back on retinoic acid signaling established its mode of intersecting with other receptor pathways.\",\n      \"evidence\": \"Yeast/mammalian two-hybrid, pull-down, EMSA, GFP imaging, and reporter assays with mutagenesis\",\n      \"pmids\": [\"9737983\", \"9556573\", \"9593676\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological context of receptor crosstalk untested in vivo\", \"Cell-type specificity of competition not defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Conformational analyses on DR3 versus DR4 elements answered how a single receptor produces opposite transcriptional outputs, showing element-induced TR4 conformations select distinct coregulators.\",\n      \"evidence\": \"EMSA, antibody supershift, proteolytic footprinting, and reporter assays\",\n      \"pmids\": [\"10347174\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific coregulators recruited to each conformation not identified\", \"Structural basis inferred indirectly\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Purifying the endogenous DRED complex and showing TR2/TR4 occupy embryonic globin DR1 sites identified the receptor's central role in developmental hemoglobin switching.\",\n      \"evidence\": \"Biochemical purification with mass spectrometry, EMSA, and transgenic mice\",\n      \"pmids\": [\"12093744\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full corepressor composition not yet defined\", \"Mechanism of stage-selectivity unresolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Selective cofactors and direct receptor inhibition were defined: TRA16 and (later) TIP27 repress TR4 via its LBD/DBD, and TR4 directly inhibits ER dimerization, mapping protein-level control of TR4 output.\",\n      \"evidence\": \"Two-hybrid, Co-IP, GST pull-down, EMSA, and proliferation assays\",\n      \"pmids\": [\"12486131\", \"11844790\", \"15302918\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological relevance of TRA16/TIP27 repression in vivo unestablished\", \"Tissue distribution of these cofactors unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of apoE/apoC and HBV core promoter targets showed TR4 directly regulates lipoprotein metabolism and can repress viral transcription through receptor crosstalk, with knockout mice confirming the apoE link in vivo.\",\n      \"evidence\": \"Gel shift, reporter assays, Co-IP, and TR4 knockout mice\",\n      \"pmids\": [\"12954636\", \"12522137\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of TR4 to systemic lipid homeostasis not isolated\", \"HNF4α interaction interface not mapped\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Genetic mouse models resolved the in vivo developmental function of TR2/TR4 as stage-selective repressors of embryonic globins and direct repressors of GATA1, anchoring the in vitro DRED model in physiology.\",\n      \"evidence\": \"Null and transgenic mice, dominant-negative TR4, ChIP, EMSA, and CD34+ knockdown\",\n      \"pmids\": [\"17431400\", \"17974920\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Paradoxical γ-globin induction by forced expression mechanistically unexplained\", \"Relative contributions of TR2 vs TR4 not separated\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Knockout phenotypes established TR4 as a direct transcriptional driver of gluconeogenesis via PEPCK, extending its role into systemic glucose metabolism.\",\n      \"evidence\": \"Knockout mice, EMSA, ChIP, reporter, RNAi, and glucose production assays\",\n      \"pmids\": [\"17827404\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals controlling hepatic TR4 activity unclear\", \"Coregulators at the PEPCK promoter unidentified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showing TR4 transactivates CD36 in response to fatty acid metabolites and TZDs defined TR4 as a lipid/fatty-acid sensor controlling foam-cell formation.\",\n      \"evidence\": \"Knockout mice, EMSA, ChIP, siRNA/rescue, and foam-cell and reporter assays\",\n      \"pmids\": [\"19666541\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous high-affinity ligand not definitively established\", \"Direct ligand binding not measured in this study\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The LBD crystal structure answered why TR4 is an 'orphan' with low basal activity, revealing an autorepressed pocket that retinoids relieve to enable coactivator recruitment.\",\n      \"evidence\": \"X-ray crystallography, coactivator recruitment, reporter assays, and mutagenesis\",\n      \"pmids\": [\"21068381\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological endogenous ligand not crystallized\", \"Conformational dynamics in solution not captured\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Comprehensive metabolic knockout studies established that TR4 loss confers resistance to metabolic syndrome, integrating TR4 into whole-body lipid and energy homeostasis.\",\n      \"evidence\": \"Knockout mice, expression profiling, and metabolic and hepatocyte rescue studies\",\n      \"pmids\": [\"20864514\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific contributions not dissected\", \"Direct vs indirect target regulation not fully separated\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Genome-wide ChIP-seq tested whether the in vitro DR1 model captures TR4 chromatin occupancy, revealing most sites lack DR1 and many are co-bound with ELK4, indicating recruitment via protein-protein interactions.\",\n      \"evidence\": \"TR4 and ELK4 ChIP-seq with motif and co-occupancy analysis in four cell types\",\n      \"pmids\": [\"21126370\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct TR4-ELK4 interaction not biochemically demonstrated\", \"Functional output at DR1-less sites untested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defining the epigenetic corepressors recruited by TR2/TR4 at embryonic globin promoters explained the molecular silencing mechanism and showed multiple distinct corepressor complexes operate.\",\n      \"evidence\": \"ChIP, biotin-tag complex purification, mass spectrometry, Co-IP, and differentiation assays\",\n      \"pmids\": [\"21670149\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of complex selection at specific promoters unclear\", \"Order of corepressor assembly not defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Knockout studies extended TR4 function into mitochondrial complex I assembly (via NDUFAF1), oxidative-stress/DNA-damage defense (GADD45A), and bone formation (osteocalcin), broadening its role as a stress- and differentiation-responsive activator.\",\n      \"evidence\": \"Knockout mice, ATP/complex I assays, ChIP, EMSA, reporter, and rescue experiments\",\n      \"pmids\": [\"21622535\", \"22396141\", \"21521714\", \"22676849\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals inducing TR4 in stress contexts incompletely defined\", \"Direct vs indirect regulation of some targets uncertain\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Discovery that ARA55 promotes acetylation of TR4 DBD lysines K175/K176 to reduce DNA binding established post-translational modification as a direct lever on TR4 activity.\",\n      \"evidence\": \"Site-directed mutagenesis, Co-IP, DNA-binding, and reporter assays\",\n      \"pmids\": [\"21515881\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The responsible acetyltransferase not identified\", \"In vivo relevance of acetylation untested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Forced TR2/TR4 expression in a sickle-cell mouse model demonstrated therapeutic-relevant induction of fetal hemoglobin, linking the repressor mechanism to hemoglobinopathy intervention.\",\n      \"evidence\": \"Humanized sickle-cell transgenic mice with hematological readouts\",\n      \"pmids\": [\"22042865\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of paradoxical γ-globin activation unresolved\", \"Translation to human therapy untested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Demonstrating MAPK-phosphorylation-enhanced TR4 activation of POMC in corticotroph tumors revealed a phosphorylation-regulated oncogenic transactivation function.\",\n      \"evidence\": \"Overexpression/knockdown, reporter assays with MAPK inhibitors, and xenograft model\",\n      \"pmids\": [\"23653479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"MAPK phosphorylation site(s) not mapped\", \"Upstream activating signals in tumors unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"ITC and structural identification of a mycobacterial keto-mycolic acid as a TR4 ligand established that TR4 senses pathogen-derived lipids to drive foamy macrophage and granuloma formation.\",\n      \"evidence\": \"Transactivation, ITC, TLC/NMR, and granuloma models\",\n      \"pmids\": [\"24907344\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of the keto-MA-LBD interaction not solved\", \"Generality across mycolic acid species untested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Multiple cancer studies dissected context-dependent TR4 roles—tumor suppressor via ATM in prostate cancer initiation versus pro-metastatic via CCL2 and stemness/chemoresistance axes—revealing dual oncogenic and suppressive functions.\",\n      \"evidence\": \"Knockout and xenograft mouse models, ChIP, reporter, and rescue/neutralization experiments\",\n      \"pmids\": [\"24583925\", \"24975468\", \"23609451\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"What dictates suppressor vs promoter context unresolved\", \"Most downstream axes shown in single labs\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of pyruvate carboxylase as a direct TR4 target connected TR4 transcriptional activity to de novo fatty acid synthesis in adipocytes.\",\n      \"evidence\": \"Reporter, ChIP, siRNA epistasis, and radiolabeled carbon incorporation assays\",\n      \"pmids\": [\"25240193\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo contribution to lipogenesis not isolated\", \"Coregulators at PC promoter unidentified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Conditional adult-bone-marrow knockout confirmed that loss of TR2/TR4 occupancy de-represses embryonic globins and is required for terminal erythroid maturation, separating developmental silencing from cell viability.\",\n      \"evidence\": \"Conditional knockout mice, in vitro differentiation, and ChIP\",\n      \"pmids\": [\"25561507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of maturation requirement not fully defined\", \"Redundancy between TR2 and TR4 not resolved here\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Two findings defined TR4 protein-level regulation and a non-redundant erythroid role: SIRT7/DDB1 deacetylation protects TR4 from CUL4B-mediated degradation, and TR4-specific knockout causes embryonic lethality with heme-biosynthesis defects.\",\n      \"evidence\": \"Co-IP, K1121R mutagenesis, qPCR, and congenic conditional knockout mice\",\n      \"pmids\": [\"28623141\", \"29018082\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase regulation of TR4 in physiological contexts incompletely mapped\", \"TR4-specific vs TR2/TR4-shared targets only partly resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"ccRCC studies established TR4-centered miRNA/oncogene axes (miR-32-5p/HGF/Met and miR-490-3p/vimentin) driving metastasis and vasculogenic mimicry, expanding TR4's regulatory reach to non-coding RNA networks.\",\n      \"evidence\": \"3'UTR targeting, ChIP/reporter at TR4REs, invasion assays, and xenograft models\",\n      \"pmids\": [\"29396852\", \"29973687\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab pathway dissections\", \"Clinical generalizability untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Bexarotene was shown to directly bind the TR4 LBD, induce a conformational change and nuclear-to-cytoplasmic relocalization, providing a pharmacological strategy to inhibit TR4-driven POMC/ACTH output.\",\n      \"evidence\": \"Virtual screening, conformational and fractionation assays, ChIP/reporter, and xenograft model\",\n      \"pmids\": [\"33491272\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Binding pose not solved by crystallography\", \"Specificity over related receptors not fully tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of NR2C2-driven NF-κB activation in macrophages linked the receptor to inflammatory cytokine production and testicular inflammation, defining an immune-regulatory function.\",\n      \"evidence\": \"RNAi in primary macrophages, DR-element binding, cytokine assays, and LPS-orchitis mouse model\",\n      \"pmids\": [\"37427695\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ChIP occupancy at the Nfkb promoter only implied\", \"Generality beyond testicular macrophages untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Resolving the long-standing question of how TR4 represses γ-globin, this work showed TR4 and BCL11A compete at the -117 γ-globin promoter region but TR4 acts independently of BCL11A and binds the locus control region genome-wide.\",\n      \"evidence\": \"In vitro binding competition, in vivo functional epistasis, and ChIP-seq\",\n      \"pmids\": [\"39393056\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise in vivo TR4 binding site at γ-globin promoter still ambiguous\", \"Mechanistic interplay with BCL11A at LCR not fully defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The identity of the physiological endogenous ligand(s) that relieve TR4 autorepression in vivo, and the rules determining whether TR4 activates or represses a given locus, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No endogenous high-affinity ligand defined despite retinoid/fatty-acid binding\", \"Determinants of element-dependent activation vs repression not mechanistically settled\", \"Rules governing tissue-specific corepressor recruitment unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 11, 17, 19, 20, 21, 24]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 2, 9, 18, 27, 48]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [20, 21, 33]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 12, 15, 45]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [11, 17, 19, 24]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [19, 20, 22, 25, 36]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [24]}\n    ],\n    \"complexes\": [\"DRED (TR2/TR4) repressor complex\"],\n    \"partners\": [\"TR2\", \"BCL11A\", \"ELK4\", \"Sp1\", \"ER\", \"HNF4A\", \"TIP27\", \"TRA16\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}